A NOVEL SWITCH-LIKE FUNCTION OF DELTA-CATENIN IN DENDRITE DEVELOPMENT by Baumert, Ryan
The Texas Medical Center Library 
DigitalCommons@TMC 
The University of Texas MD Anderson Cancer 
Center UTHealth Graduate School of 
Biomedical Sciences Dissertations and Theses 
(Open Access) 
The University of Texas MD Anderson Cancer 
Center UTHealth Graduate School of 
Biomedical Sciences 
12-2019 
A NOVEL SWITCH-LIKE FUNCTION OF DELTA-CATENIN IN 
DENDRITE DEVELOPMENT 
Ryan Baumert 
Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations 
 Part of the Biochemistry Commons, Cell Biology Commons, Developmental Neuroscience Commons, 
Medicine and Health Sciences Commons, and the Molecular and Cellular Neuroscience Commons 
Recommended Citation 
Baumert, Ryan, "A NOVEL SWITCH-LIKE FUNCTION OF DELTA-CATENIN IN DENDRITE DEVELOPMENT" 
(2019). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical 
Sciences Dissertations and Theses (Open Access). 986. 
https://digitalcommons.library.tmc.edu/utgsbs_dissertations/986 
This Dissertation (PhD) is brought to you for free and 
open access by the The University of Texas MD Anderson 
Cancer Center UTHealth Graduate School of Biomedical 
Sciences at DigitalCommons@TMC. It has been 
accepted for inclusion in The University of Texas MD 
Anderson Cancer Center UTHealth Graduate School of 
Biomedical Sciences Dissertations and Theses (Open 
Access) by an authorized administrator of 




A NOVEL SWITCH-LIKE FUNCTION OF DELTA-CATENIN IN DENDRITE 
DEVELOPMENT 
by 





































Dean, The University of Texas 











Presented to the Faculty of  
 
The University of Texas 
MD Anderson Cancer Center UTHealth  
Graduate School of Biomedical Sciences  
 
in Partial Fulfillment 
of the Requirements 
for the Degree of 
 













I would like to dedicate this work to my parents, Michael and Elizabeth, my aunt, Marjorie, and my 
incredible partner, Erika. Their unyielding love and support has allowed me to become the person I 
am today and without them, none of this work would have been possible. 
 
I would also like to dedicate this work to my grandfather, Edward, who, during the time we shared 
together, never missed the chance to excite my passion for science and helped fuel my drive to 





First, I would like to thank my incredible mentor, Pierre D. McCrea, Ph.D. for his endless 
support and patience throughout my studies at GSBS. During my time as a student in his lab, he 
consistently encouraged and facilitated the progression of my career, and always pushed me to do 
the best work possible. He has been the kindest and most supportive mentor I could have ever 
asked for. For all of this, I am truly appreciative. 
I would like to thank my committee member and collaborator, Neal Waxham, Ph.D. for his 
invaluable advice and support. He constantly pushed me to ask meaningful questions during my 
studies, and without him this research would not have been possible. I deeply appreciate his 
contributions and guidance. 
I would also like to thank all members of my advisory committee: Darren Boehning, Ph.D.; 
Eric Swindell, Ph.D.; and Jack Waymire, Ph.D. Their guidance, support, and meaningful conversations 
were incredibly valuable to my development as a scientist, and I am greatly appreciative of them. 
In addition, I would like to thank the current and past members of the McCrea and Miller 
labs: Hong Ji, Moonsup Lee, Ph.D.; Jessica Zapata, Ph.D.; Kevin Stebbings, Ph.D.; Rachel Miller, Ph.D.; 
Bridget DeLay, Ph.D; Mark Corkins, Ph.D.; Vanja Stankic, and Alex Blackburn. Their insight and 
guidance throughout my training at GSBS has been invaluable, and I very much appreciate them for 
all of their support over the years. 
I would like to thank the Neuroscience and Genetics & Epigenetics programs, especially 
Amanda Williamson and Elisabeth Lindheim. The Neuroscience program has offered a constant 
stream of guidance and support, and the Genetics & Epigenetics program always made a point to 
include me in events and offer as much support as possible. For this I am greatly appreciative.  The 
Genetics Department at MD Anderson Cancer Center has also provided me with endless support 
v 
 
and a wonderful training environment, and I am very thankful to have been surrounded by such 
wonderful people during my studies at GSBS. 
There are so many others who have guided me in one way or another over the years, and I 
would like to thank everyone at the GSBS for their friendship and support during my studies. 
Lastly, I would like to thank my parents and my partner, Erika, for their love and support 




A NOVEL SWITCH-LIKE FUNCTION OF DELTA-CATENIN IN 
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The formation of neuronal networks in the brain is tightly regulated, and dependent on the 
morphology of dendrites, the branch-like signal-receiving structures extending from neurons. 
Disruptions in dendrite development, or dendritogenesis, can lead to the atypical neuronal 
connectivity associated with multiple neurodevelopmental diseases. My research addresses 
molecular processes that underlie dendritogenesis via analysis of a pair of novel interactions 
involving the protein delta-catenin. 
 In neurons, delta-catenin localizes to dendrites and synapses, where it functions in their 
development and maintenance. Structurally, delta-catenin possesses a central Armadillo domain 
and a C-terminal PDZ-binding motif. This motif associates with PDZ domain-containing proteins, and 
is crucial for the neuronal functions of delta-catenin. My research has revealed two novel 
interactions between delta-catenin and the PDZ domain-containing proteins Magi1 and Pdlim5.  
Through the use of cell-lines and primary neuronal cultures, I have begun to reveal the 
functions of these proteins in dendrite development. My findings suggest that delta-catenin is 
required for the extension of dendrites, and induces dendritic branching during neuronal 
development. My work has also shown that Magi1 promotes dendrite extension, but not dendritic 
branching. Conversely, Pdlim5 appears to function in restricting dendrite growth, while 
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simultaneously promoting dendritic branching. This presented me with the perplexing thought that 
either of these two proteins, with seemingly opposing dendritic roles, can each bind the PDZ-binding 
motif of delta-catenin. 
Further analysis of these proteins revealed a potential “phospho-switch” mechanism in the 
function of delta-catenin. Specifically, I found a pair of critical serine residues within delta-catenin 
(S1245 and S1242), that enable it to bind Magi1 (when unphosphorylated) or Pdlim5 (when 
phosphorylated). Expressing delta-catenin mutants, which mimic the unphosphorylated versus 
phosphorylated state, shifted its function between promoting dendrite elongation or branching, 
respectively. Looking upstream of delta-catenin phosphorylation, my findings implicate the 
glutamate receptor mGluR5, which has extensive roles in dendrite development, in this pathway. 
Lastly, my investigation suggested that Rho-family GTPases lie downstream of these delta-catenin 
complexes, thereby linking them to cytoskeletal regulators with established roles in dendritogenesis. 
Overall, my research furthers our understanding of the mechanisms underlying dendrite 
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Dendrites and their functions in the nervous system: 
Dendrites are the branch-like structures that extend out from most neurons and are responsible for 
receiving most of the signals a cell receives from the neurons it is associated with (Figure 1). These 
signals are transmitted across specialized cell-cell junctions known as synapses, which typically form 
between a dendrite and an axon terminal, the second specialized branch-like structure of a neuron. 
Because the vast majority of these synapses form on dendrites, the formation of a functional 
network of neurons in the brain is highly dependent on the proper development of dendrites, a 
process known as dendritogenesis. 
 
Dendritogenesis is a tightly regulated process that relies on the organized branching and elongation 
of neurites, or the protrusions from a neuron’s cell body (soma) that ultimately develop into 
dendrites. Abnormal dendrite development can lead to atypical synaptic connectivity in the brain, 
and has been linked to multiple neurodevelopmental and cognitive disorders. Specifically, in Down’s 
syndrome patients, infants appear to possess abnormally long and over-branched dendrites, with 
patients over the age of 2 years exhibiting severely shortened and under-branched dendrites when 
compared to controls (Becker, Armstrong, and Chan 1986). In contrast, Rhett Syndrome patients 
show reductions in dendrite branching throughout life, with severe defects in dendrite morphology 
being first apparent very early in brain development (Armstrong et al. 1995). In Autism Spectrum 
Disorder, which is often associated with other mental disorders, reduced dendritic branching in the 
CA1 and CA4 regions of the hippocampus have been observed in patients, and several Autism-
related genes and genetic models have also been shown to result in neurons with restricted 
dendritic arbors (Kulkarni and Firestein 2012; Raymond, Bauman, and Kemper 1995). Reduced 
dendritic arbor size (lack of both elongation and branching) has also been observed in the brains of 




Figure 1. Simplified diagram of a neuron. 
 
Dendrites are the branch-like structures that extend out from the cell body (Soma) of a neuron. They 
are largely responsible for the receiving of synaptic input from the presynaptic axons of other 
neurons. Dendrites extend and branch in a highly orchestrated manner in order to establish 




normal (Broadbelt, Byne, and Jones 2002). Additionally, chronic stress, anxiety, and depression have 
also been linked to dendrite atrophy and reductions in dendritic arbor size in the hippocampus (in 
both humans and mouse models), both of which are believed to be related to elevated levels of 
stress-response hormones, such as corticosterone (Radley et al. 2004; Kulkarni and Firestein 2012; 
Soetanto et al. 2010). Lastly, reductions in dendritic arbor size have been observed during the 
progression of Alzheimer’s disease, although these changes in dendrite morphology are related to 
the deterioration of dendritic structures, rather than defects in their development (Avila et al. 2017). 
Nevertheless, the prevalence of disrupted dendrite morphologies in these cognitive disorders 
strongly suggests a key role of dendrites in the normal functioning of the central nervous system, 
and calls for a need to establish a better understanding of the development and function of these 
neuronal structures. 
 
It is also worth noting that all of the above studies are in reference specifically to dendrite 
morphology. Many of those mentioned, and numerous additional cognitive disorders, have been 
strongly linked to the abnormal development and organization of dendritic spines, which are the 
dendritic structures that directly compose synapses, and whose development may be dependent on 
some of the same pathways underlying dendrite development (Kulkarni and Firestein 2012). 
Nevertheless, developing a better understanding of the pathways underlying dendrite formation 
may provide insight into the mechanisms responsible for the atypical dendrite morphology 
associated with the above neurodevelopmental and cognitive disorders, and in turn, assist in the 





Dendrite morphology and specification: 
Dendrite and axon morphological differences: 
During neuronal development, neurons begin extending protrusions out from the cell body, or 
soma. These protrusions, known as neurites, are the structures that eventually become specialized 
branch-like structures known as dendrites, with typically a single neurite developing into the axon of 
a neuron. Despite their similar origins, dendrites and axons serve vastly different roles in the 
nervous system, with dendrites typically receiving signals from other cells and axons typically 
transmitting signals to other cells. While this work is focused solely on dendrite morphology, it is 
worth noting the functional, structural, and developmental differences between axons and 
dendrites in order to provide a more detailed description of dendrite development. The 
specification of a single axon from the neurites of a neuron is a key aspect of neuronal polarization 
and development. During development, a single neurite is often observed to grow much more 
rapidly than its counterparts. This elongated neurite will eventually become the axon, and while the 
precise mechanism by which this future axon is determined remains unknown, there are several 
observed factors that contribute to the dendrite-axon specification process that will be covered 
later in this section. 
 
Perhaps the most notable difference between axons and dendrites is the presence of dendritic 
spines along the lengths of mature dendrites. First described over 100 years ago by Santiago Ramon 
y Cajal, these relatively short protrusions act as the receiving end of most excitatory synapses and 
interface with the pre-synaptic axon to form a synapse (Ramón Y Cajal 1888, 1899). While dendritic 
spines exist in a variety of shapes, the most classical representation is a short “mushroom-shaped” 
protrusion with a thin neck and a bulbous head, which contains the post-synaptic density (Ethell and 
Pasquale 2005). The post-synaptic density comprises a highly-specialized densely packed region of 
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ion channels and receptors associated with synaptic signal transmission, as well as scaffold proteins 
which link the density to the actin cytoskeleton of the dendritic spine (Hering and Sheng 2001). This 
post-synaptic density is the primary point of signal reception on dendrites from pre-synaptic axons 
and undergoes constant remodeling throughout the life of a neuron as synaptic connections 
strengthen and weaken in response to changes in neuronal activity, and often occurs in the form of 
redistribution of neurotransmitter receptor and ion channel pools (Hering and Sheng 2001). 
Remodeling of the broader spine morphology occurs, in part, due to dynamic regulation of the 
cytoskeleton of dendritic spines (Colgan and Yasuda 2014). While the dendrite cytoskeleton is 
composed of both microtubules and actin filaments, dendritic spines mostly lack microtubules, and 
are largely supported by a highly dynamic actin network (Hering and Sheng 2001). This actin 
network acts as the primary supporting structure responsible for dendritic spine development and 
remodeling throughout the life of the neuron, and forms unique structural networks within the 
spine (AY Nakayama, Harms, and Luo 2000; Hering and Sheng 2001). Several groups have found that 
actin assembles into longitudinal bundles in the spine neck and a meshwork in the spine head, with 
the dynamics of both structures contributing to the remodeling of dendritic spine morphology 
(Korobova and Svitkina 2010; Ethell and Pasquale 2005). Dendritic spine actin dynamics, and 
subsequently dendritic spine morphology, is largely regulated by Rho-family GTPases and several 
other actin-associated proteins during both synaptic development and remodeling (Govek, Newey, 
and Van Aelst 2005; AY Nakayama, Harms, and Luo 2000). These actin regulatory proteins have 
diverse roles and upstream signaling components in the context of synapse development and 
remodeling, and are each crucial for the formation of functional dendritic spines. 
 
The cytoskeletal regulatory roles of Rho-family GTPases, particularly RhoA, Rac1, and Cdc42, are 
perhaps the best-characterized actin regulators in the context of dendrite spines (AY Nakayama, 
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Harms, and Luo 2000; Luo 2000). All three of these molecules are expressed nearly ubiquitously in 
neurons and, interestingly, have distinct roles in the development and remodeling of dendritic 
spines and the actin network that supports them (Olenik et al. 1997; Ethell and Pasquale 2005). 
Studies involving the expression of constitutively active Rac1 revealed the formation of increased 
densities of spines along dendrites, both in vivo and in vitro (Luo et al. 1996; Tashiro, Minden, and 
Yuste 2000). Interestingly, these dendritic spines are long and thin when compared to normal 
spines, and generally lack the ability to form functional synapses in vitro, suggesting that Rac1 may 
function primarily in the initial formation of dendritic spine protrusions, but is downregulated during 
later stages of spine development (Govek, Newey, and Van Aelst 2005; AY Nakayama, Harms, and 
Luo 2000; Tashiro, Minden, and Yuste 2000; H. Zhang et al. 2003). In agreement with these findings, 
expression of a dominant negative Rac1 in hippocampal neurons results in a reduced number of 
dendritic spines and synapses, further supporting the role of Rac1 in spine formation (AY Nakayama, 
Harms, and Luo 2000; Penzes et al. 2003; H. Zhang et al. 2003). In contrast to the function of Rac1, 
RhoA is believed to function in dendritic spine retraction, as expression of a constitutively active 
RhoA has been shown to reduce the overall number of dendritic spines in hippocampal neurons. 
Interestingly, when RhoA activity was inhibited in these studies, neurons developed an increased 
number of dendritic spines, with long and thing morphologies resembling that of constitutively Rac1 
expression (Govek, Newey, and Van Aelst 2005; Tashiro, Minden, and Yuste 2000). The third Rho-
family GTPase implicated in dendritic spine development, Cdc42, is not as well understood by 
researchers in this context as its relatives. Nevertheless, expression of a dominant-negative Cdc42 in 
hippocampal neurons results in decreased dendritic spine densities along dendrites, suggesting that 
this protein does in fact play a role in spine development (Irie and Yamaguchi 2002). Taken together, 
these findings reveal key roles of the Rho-family GTPases in dendritic spine development, likely 
through their regulation of actin dynamics.  
8 
 
While the development and remodeling of dendritic spines have been heavily studied, the 
mechanism of their initial formation remains highly debated, as numerous mechanisms have been 
observed. One such mechanism is via filopodial precursor structures, which project from dendrites 
and have been linked to spine formation, as these structures have been found to interact with 
nearby axon terminals (Ziv and Smith 1996). Additionally, it has been shown that glutamate signaling 
induces the formation of these dendritic protrusions, which supports the theory that pre-synaptic 
signaling contributes to filopodia development, though the ultimate fate of these glutamate-induced 
formations remains to be determined (Portera-Cailliau, Pan, and Yuste 2003). A second proposed 
mechanism of dendritic spine formation is their formation around synapses along the dendrite shaft. 
This theory is based on the observation that relatively few synapses actually form of filopodia, with 
most forming on the dendrite shaft prior to spine formation (Harris, Jensen, and Tsao 1992). 
Further, the relative proportion of shaft synapses decreases as dendritic spine-based synapses begin 
to arise (Dailey and Smith 1996). In addition to these examples of pre-synaptic signaling events 
inducing spine formation, the development of dendritic spines prior to any pre-synaptic contacts has 
also been observed in certain contexts, signifying that the development of dendritic spines can occur 
through pathways independent of cues from nearby axons (Sotelo 1990; Takács et al. 1997). The 
evidence supporting each of these theories of spine formation suggests that there are numerous 
factors that can contribute to the formation and further development of these structures. While 
beyond the scope of this work, it will be interesting to learn how the mechanisms of dendrite 
development revealed here interplay with the pathways underlying dendritic spine development. In 
summation, dendritic spine development is a complex and tightly regulated process with remodeling 
of these structures occurring throughout the life of a neuron. Further, dendritic spines represent a 
morphological feature unique to dendrites, and contribute to the distinct roles of dendrites in the 
transmission of neuronal signals. 
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In addition to the presence of dendritic spines, dendrites exhibit several key differences from their 
axon counterparts that allow the two structures to fulfill distinct roles in the nervous system. The 
two most iconic markers of these structures, MAP2 (dendrites) and Tau (axons), are both 
microtubule-associated proteins that have functions in neuronal polarity (Dehmelt and Halpain 
2004). The differential localization of MAP2 and Tau to dendrites and axons, respectively, is believed 
to stem from a combination of interaction stability and mRNA transport (Hirokawa et al. 1996; Kanai 
and Hirokawa 1995; Garner, Tucker, and Matus 1988). Specifically, it has been found that Tau 
becomes localized to axons through the destabilization of its microtubule association via 
phosphorylation events that occur in dendrites, but not in axons (Utton et al. 2005; Wagner et al. 
1996; Kanai and Hirokawa 1995). Localization of MAP2 to dendrites has been found to be the result 
of MAP2 mRNA transport to the dendrites, as well as the N-terminal projection domain of MAP2 
preventing it from entering the axon (Kanai and Hirokawa 1995; Garner, Tucker, and Matus 1988). 
Additionally, while recent studies have found that axons and dendrites share many similarities at the 
cytoskeletal level, there do exist differences in cytoskeleton organization between these two types 
of neuronal protrusions (Konietzny, Bär, and Mikhaylova 2017; Coles and Bradke 2015). Namely, the 
polarity of microtubules (plus versus minus end) is highly diverse in dendrites, while in axons, 
microtubules largely orient with their plus ends facing away from the cell body (Baas et al. 1988). 
These differences in microtubule polarity are associated with the different cargo transport functions 
of axons and dendrites, acting as one of the many features that generate the vastly different roles of 
these structures in the nervous system (Kapitein et al. 2010). Additionally, until recently, another 
key difference between the cytoskeletal organization of axons and dendrites was believed to be the 
presence of highly organized actin ”rings” in axons, also known as the membrane-associated 
periodic skeleton, which function to maintain microtubule organization in these protrusions (K. Xu, 
Zhong, and Zhuang 2013). However, recent findings suggest that these actin rings are also present in 
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some dendrites, although they are much less prevalent here. At 5 days in vitro (DIV), virtually all 
axons in the hippocampus exhibit actin rings, while only around 25% of dendrites have a detectable 
similar actin organization (D’Este et al. 2015). Current evidence suggests that these actin rings 
precede axon specification, and may function in the development of a single axon during this 
process (D’Este et al. 2015; Unsain, Stefani, and Cáceres 2018). Given the similar origins and 
comparable structures, yet very different functions, of axons and dendrites, dendrite-axon 
specification is a crucial process in neuronal development and will be covered in the following 
section, as it plays into the structure and function of both of these structures.  
 
Dendrite-axon specification: 
During dendrite-axon specification, numerous intrinsic and extrinsic positive/negative feedback 
signaling events are known to occur. It has been shown that the localized expression of the proteins 
mPar3 and mPar6 are crucial for axon specification (Insolera, Chen, and Shi 2011). Both mPar3 and 
mPar6 are PDZ domain-containing scaffold proteins, and rely on their PDZ domains for axon 
specification (Insolera, Chen, and Shi 2011). The roles of many PDZ domain-containing proteins 
extend throughout neuronal development, and will be addressed in detail later in this section. 
Nonetheless, during dendrite-axon specification, mPar3 and mPar6 become strongly localized to the 
newly forming axon and its growth cone, and ectopic expression of either of these proteins prevents 
the formation of a distinct axonal projection from the cell (Nishimura et al. 2004). Additionally, in 
many cases of generation of cell polarity, mPar3 and mPar6 associate with the kinase aPKC, and 
form a complex crucial to the establishment of cell and embryo polarity (Suzuki and Ohno 2006). 
This complex also appears to be relevant to neuronal polarity, as inhibition of aPKC activity inhibits 
axon specification, much like what is observed following disrupted expression of mPar3 and mPar6 
(Nishimura et al. 2004; Wiggin, Fawcett, and Pawson 2005). This mPar3/mPar6/aPKC complex has 
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been shown to regulate small GTPase activity in neurons and other cells, and is believed to 
contribute to the cytoskeletal changes that govern the formation of a mature axon (Wiggin, Fawcett, 
and Pawson 2005; Nishimura et al. 2005). In fact, this complex can directly bind the GTPase Cdc42, 
which has been shown to be required for normal axon development, and whose activity can directly 
influence dendrite-axon specification (Nishimura et al. 2005; Joberty et al. 2000). Further, the 
mPar3/mPar6/aPKC complex binds directly to Tiam1 and STEF (Tiam2), which are two guanine 
nucleotide exchange factors (GEFs) that activate the Rho-family small GTPase, Rac1, yet another 
protein crucial for the initiation of axon specification (Nishimura et al. 2005). Despite their well-
established roles in neuronal polarity signaling, it has not yet been established whether the 
mPar3/mPar6/aPKC complex lies upstream or downstream of the Rho-family GTPases in axon 
specification, as each appears to be able to activate the other during this process (Wiggin, Fawcett, 
and Pawson 2005; Nishimura et al. 2005; D. Lin et al. 2000). However, it remains true that 
localization of the mPar3/mPar6/aPKC complex to the future axon, as well as localized activation of 
Cdc42 and Rac1 in this region, both promote and are required for dendrite-axon specification in 
neurons of the central nervous system (Shi, Jan, and Jan 2003; Schwamborn and Püschel 2004). 
 
Upstream of the mPar3/mPar6/aPKC and Rho GTPase pathway is the kinase PI3K, which also 
exhibits localized activation in the future axon during dendrite-axon specification. Localization of 
activated PI3K to the future axon has been shown to be essential for axon specification, and 
inhibition of the kinase via overexpression of its negative regulating protein, PTEN, prevents 
neuronal polarization (Shi, Jan, and Jan 2003). Additionally, inhibition of PI3K activity prevents 
localization of Par3 to the axon, which, in addition to regulating small GTPases and other 
cytoskeletion-regulating proteins, is believed to be one mechanism by which PI3K influences axon 
specification (Shi, Jan, and Jan 2003; Jiang et al. 2005). The role of PI3K activity in the recruitment of 
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the mPar3/mPar6/aPKC complex during dendrite-axon specification also ties into the many extrinsic 
factors that contribute to this process.  Specifically, one of the primary extrinsic regulators of axon 
specification is the neurotrophin family of molecules. This family includes molecules such as the 
brain-derived neurotrophic factor (BDNF) and Neurotrophin-3, which activate the tyrosine receptor 
kinase, TrkB, and promotes axon specification during neuronal development, whereas inhibition of 
the TrkB receptor impairs it (Cheng et al. 2011; Nakamuta et al. 2011). PI3K lies downstream of TrkB 
activation, which activates the Ras GTPase, a key regulator of PI3K activity (Shi, Jan, and Jan 2003). 
In addition to neurotrophin signaling, the localized presence of transforming growth factor-β (TGF-β) 
signaling also promotes axon specification (Yi et al. 2010). Interestingly, the impact of TGF-β 
signaling on dendrite-axon specification has been shown to be dependent on the presence of 
mPar6, as phosphorylation of mPar6 lies downstream of TGF-β receptor activation (Yi et al. 2010). In 
summary, there are numerous crucial signal transduction events and morphological changes that 
occur during axon and, in turn, dendrite specification prior to the signaling events and related 
morphological impacts described in this work.  
 
It is also worth noting that, in addition to the intrinsic and extrinsic signaling pathways described 
here, there are many additional factors that have been observed to contribute to dendrite-axon 
specification (Slit-Robo signaling, Ephrin signaling, adhesion molecules, and other Par proteins). 
However, those related to the mPar3/mPar6/aPKC complex are currently the best understood, and 
are thus the focus of this overview. To summarize, while the exact mechanisms underlying dendrite-
axon specification are not fully understood, a combination of extrinsic and intrinsic factors converge 
to generate neuronal polarity, and ultimately give rise to the formation of a singular axon and the 
numerous dendrites that are characteristic of most neurons in the central nervous system. However, 
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once specified, these structures continue to undergo numerous morphological changes before they 





Dendrite development after specification: 
Following dendrite-axon specification, but before spine formation, there are several known 
mechanisms which have been observed to underlie dendrite development and the formation of 
adequately complex dendritic arbors. Much like the numerous intersecting pathways that contribute 
to dendrite-axon specification, there are also many factors that combine to influence post-
specification vertebrate dendrite development. The pathways best understood in this context, along 
with those most closely related to the work described here, will be the focus of this section. 
 
Transcriptional events influencing dendrite development: 
In the nuclei of mammalian neurons, transcription factors such as Neurogenin 2, Cux1, and Cux2 all 
contribute to the morphology of dendritic arbors (Dong, Shen, and Bülow 2015). Neurogenin 2 
(Ngn2) has been shown to be required for the development of pyramidal neuron dendrites, and 
neurons lacking Ngn2 form highly disorganized dendritic arbors (Hand et al. 2005). This function of 
Ngn2 appears to be linked to the inhibition of the small GTPase RhoA, as two target genes of Ngn2 
are RhoGAP5 and FNBP2, which both function to inhibit RhoA activity in neurons (Hand et al. 2005). 
RhoA activity functions to inhibit dendritic outgrowth and branching through regulation of 
cytoskeletal remodeling, and a more detailed analysis of the roles of these small GTPases in dendrite 
development will be covered later in this section (Threadgill, Bobb, and Ghosh 1997). Like Ngn2, the 
transcription factors Cux1 and Cux2 are also required for normal dendrite development, and mice 
lacking these transcription factors develop neurons with significantly reduced dendrite length and 
branch number (Cubelos et al. 2010). Cux1 and Cux2 are believed to impact dendrite morphology 
through the upregulation of β-actin protein expression, a protein with established roles in dendrite 
elongation (Cubelos et al. 2010; Ammer and Weed 2008). Additionally, while it is not yet fully 
understood how Cux1 and Cux2 regulate dendrite morphology beyond their regulation of β-actin 
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expression, two of their target genes, Xlr4b and Xlr3b, contribute to dendritic spine development 
and function in mammalian neurons (Cubelos et al. 2010). While there have not yet been many 
studies on the roles of mammalian transcription factors in the development of dendrites, the 
observations described above, combined with similar findings in invertebrate model organisms, 
primarily Drosophila, make it clear that transcriptional regulation of neuronal genes play a key roles 
in the formation of dendritic arbors during development (Dong, Shen, and Bülow 2015). 
 
Extrinsic factors influencing dendrite development: 
In additional to transcription events in the nuclei of neurons, several extrinsic factors also contribute 
to early dendrite development. Interestingly, many of these extrinsic signaling cues also have roles 
in axon specification, as described above. For instance, several members of the neurotrophin family 
of signaling molecules, which includes nerve growth factor (NGF), brain-derived growth factor 
(BDNF), neurotrophin-3, and neurotrophin-4, have been found to contribute to dendritic elaboration 
(McAllister, Lo, and Katz 1995). These molecules influence dendrite development via activation of 
members of the tyrosine receptor kinase (Trk) family of receptor proteins, as described above 
(Huang and Reichardt 2003). Specifically, neurons lacking the BDNF receptor, TrkB, or having 
disrupted TrkB localization, develop very simplistic, under-branched and under-extended dendrites 
(B. Xu et al. 2000; Zhou et al. 2012). Likewise, loss of the neurotrophin-3 receptor, TrkC, also results 
in the development of dendrites of severely reduced complexity, although in certain contexts, 
neurotrophin-3 signaling has been found to inhibit dendritic branching (Joo, Hippenmeyer, and Luo 
2014; McAllister, Katz, and Lo 1997). Downstream of Trk activation, Phosphoinositide 3-kinase (PI3K) 
is activated, which in turn activates the mPar3/mPar6/aPKC complex (PAR Complex), resulting in the 
downstream inhibition of glycogen synthase kinase-3beta (GSK3β) via serine phosphorylation (Rui et 
al. 2013). In hippocampal neurons, inhibition of GSK3β results in the elaboration of dendritic arbors, 
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whereas activation leads to the formation of simple protrusions with significant reductions in length 
when compared to controls (Rui et al. 2013). This Trk-mediated inhibition of GSK3β is believed to 
impact dendrite elaboration via several mechanisms, including the regulation of multiple 
transcription factors involved in neuronal development, such as CREB and neurogenin 2, as well as 
influencing cytoskeletal dynamics through the mediation of the activity of microtubule-associated 
protein (MAPs), such as APC (Zhou et al. 2012; Grimes and Jope 2001). Because of the vast roles of 
GSK3β in the regulation of developmental processes in neurons, and its strong link to the Trk 
receptors and their neurotrophin ligands, the neurotrophin family of signaling molecules are well-
positioned to be key regulators of dendritic morphology and ultimately neuronal connectivity. 
 
It worth noting that, in addition to neurotrophin signaling, multiple other extrinsic pathways that 
influence dendrite development are theorized to also converge on GSK3β to regulate gene 
transcription and cytoskeletal dynamics, and thus dendrite morphology. For instance, activation of 
the Wnt signaling pathway in neurons also results in the inhibition of GSK3β and has been shown to 
contribute to the elaboration of dendritic arbors, and overexpression of the Wnt receptor, Frizzled 
(Fz7), results in the formation of more complex arbors (Rosso et al. 2005; Y. T. Kim et al. 2011). 
However, a detailed understanding of how Wnt-mediated GSK3β inhibition intersects with the 
activity of other known neuronal mediators of GSK3β in dendrite development remains yet to be 
established. Indeed, perhaps the best characterized role of Wnt signaling in dendrite development is 
through the activation of actin regulatory proteins such as CaMKII and Rac1 (Rosso et al. 2005; 
Ferrari et al. 2018). In this pathway, locally secreted Wnt7b binds and activates the dynamically 
expressed Fz7 receptor along dendrites, and results in the recruitment of the scaffold protein 
Disheveled (Dv1) to the membrane (Ferrari et al. 2018). This dendritically localized Dv1 colocalizes 
with F-actin and can induce cytoskeletal changes through multiple known mechanisms. It can form a 
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complex with, and activate, the Rho-family small GTPase Rac1, which initiates actin cytoskeleton 
reorganization and contributes to dendrite elaboration (Esufali, Charames, and Bapat 2007; 
Threadgill, Bobb, and Ghosh 1997). Additionally, Dv1 has been found to activate CaMKII and JNK 
(Jun Kinase), both of which are known regulators of microtubule-associated proteins (MAPs), 
microtubule dynamics, and dendrite complexity (Ferrari et al. 2018). Taken together, these findings 
support a role of Wnt signaling in the growing field of extrinsic cues known to influence dendrite 
development, though many questions, such as how this pathway contributes to localized versus 
global changes in dendrite morphology, remain unanswered. Interestingly, the effects of this Wnt 
pathway appear to be specific to dendrites, as researcher found no effects on axon morphology in 
response to perturbations of Wnt7b signaling, despite Disheveled having known roles in axon 
specification and elongation (Rosso et al. 2005). These findings suggest that despite the presence of 
similar signaling components, these two compartments respond differently to extrinsic cues, with 
their responses being mediated by spatially or temporally regulated changes in the composition of 
intracellular signaling machinery populations. 
 
Believed to act in tandem with the neurotrophin and Wnt-signaling pathways described above, 
several other extrinsic cues have also been observed to function in establishing dendrite 
morphology during development. One such group of molecules is the Semaphorin family of secreted 
growth factors. Like the neurotrophins, several Seamphorin family members also play key roles in 
axon development, with functions in processes including outgrowth and pathfinding (Winberg et al. 
1998). In dendrites, Semaphorin 3A and its receptors, neuropilin-1 and PlexinA, have all been 
observed to promote the branching of dendritic protrusions during development, both in vitro and 
in vivo (Tran et al. 2009). This is believed to occur through the activation of a variety of downstream 
effectors, including Rac1 and Jun Kinase (JNK), both of which function to promote dendrite 
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branching (Cheadle and Biederer 2014; Ben-Zvi et al. 2006; Rosso et al. 2005). Semaphorin 3A 
signaling also results in the recruitment and activation of the Ca(V)2.3 calcium ion channel in 
dendrites via the triggering of increased production of the cGMP signaling molecule, which has been 
shown to promote dendritic outgrowth (Nishiyama et al. 2011). While the mechanism by which this 
Ca(V)2.3 channel-dependent role of Semaphorin 3A in dendrite development occurs remains to be 
determined, activation of Ca(V)2.3 activation in dendrites contributes to the recruitment of the 
dendritic microtubule-associated protein, MAP2, suggesting that this pathway likely mediates the 
microtubule dynamics of dendrites (Nishiyama et al. 2011). In addition to inducing cytoskeletal 
changes, Semaphorin 3A signaling also results in the recruitment of AMPA glutamate receptors and 
synaptic proteins, such as PSD-95, to the dendrite, suggesting that Semaphorin signaling perhaps 
contributes to both the branching and elongation of dendrites as well as their maturation in the 
context of forming post-synaptic densities along their lengths (Morita et al. 2006; Yamashita et al. 
2014).  
 
In the context of extrinsic growth cues, the neurotransmitter glutamate has also been strongly 
implicated in several aspects of dendrite development. Both diffuse glutamate treatment and more 
localized glutamate-induced activity have been shown to contribute to the elaboration of dendritic 
arbors in several contexts. Cultured primary hippocampal neurons treated with glutamate develop 
significantly more complex dendritic arbors when compared to controls, whereas blocking activity of 
either NMDA or AMPA receptors in cultured neurons results in the formation of less complex 
dendritic arbors (Hamad et al. 2011; Charych et al. 2006; Previtera and Firestein 2015b). Loss of 
NMDA receptor function in vivo results in similar reductions in dendrite length and complexity in 
mouse retinal ganglion cells (Elias et al. 2018). Further, pyramidal neurons of mice lacking Grm5, the 
gene that encodes the glutamate receptor mGluR5, develop significantly less complex dendritic 
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arbors than controls, suggesting that glutamate signaling can mediate dendrite morphology via 
several receptors/mechanisms (Loerwald et al. 2015). Interestingly, the mechanisms by which 
glutamate induces changes in dendrite morphology remain almost entirely unknown, though the 
neurotransmitter’s roles in dendritic spine formation are better understood and may shed light on 
its means of action in dendrites. In these structures, glutamate signaling, via NMDA receptors, 
results in a transient increase in local calcium concentrations and the activation of calmodulin 
(CaM). This ultimately leads to remodeling of the actin cytoskeleton of the spine via activation of 
Rac1, a Rho-family GTPase, by kalirin-7, a GTPase activating protein downstream of CaM activity (Xie 
et al. 2007; Soderling 2000). It is possible that glutamate’s influence on dendrite development may 
be mediated through a similar calcium and/or Rho-family GTPase-dependent pathway, though more 
work needs to be completed in the study of dendrite development before the role of glutamate 
signaling can be fully elucidated. Further, while the roles of the extrinsic cues described here have 
provided significant advancements in our understanding of dendrite development, how these 
pathways contribute to specific changes in dendrite morphology (i.e. branching vs. elongation), 
remain to be uncovered. Nevertheless, these findings demonstrate a key role of extrinsic signaling in 
dendrite development through their mediation of intrinsic changes in neurons at both the 
transcriptional and structural levels. 
 
Intrinsic factors influencing dendrite development: 
As briefly mentioned above, and in addition to transcriptional regulation of key genes, there are 
many cytoskeletal changes initiated by extrinsic cues that dendrites undergo during their 
development. Many of the pathways involved in dendrite development discussed above converge 
on the modulation of the Rho GTPase family of cytoskeletal regulatory proteins, and the cytoskeletal 
dynamics brought about by these pathways are what ultimately give rise to the morphological 
20 
 
changes that underly dendrite development. RhoA, along with two other members of the Rho family 
of small GTPases, Rac1 and Cdc42, have all been strongly implicated in the formation and 
elaboration of dendritic arbors during neuronal development. These proteins act as molecular 
switches for downstream effectors as they cycle between their GDP-bound inactive state and their 
GTP-bound active state (Threadgill, Bobb, and Ghosh 1997). Rho-family GTPases are typically 
activated by a guanine exchange factor (GEF) protein, which functions to facilitate the exchange of 
GDP for GTP (Schmidt and Hall 2002). Once active, the Rho-family GTPases regulate actin 
cytoskeleton remodeling through the direct and indirect activation of several proteins/complexes, 
such as ROCK, LIMK, Cofilin, Arp2/3 and WAVE, all of which can directly or indirectly mediate 
cytoskeletal dynamics (Maekawa et al. 1999; T. Lin et al. 2003; Nakanishi et al. 2007; Miki, Suetsugu, 
and Takenawa 1998).  
 
In the context of dendrite development, the GTPase RhoA has been found to negatively regulate 
dendrite branching and outgrowth. Expression of a constitutively active RhoA results in dendritic 
arbors of significantly reduced size in rat hippocampal neurons and Xenopus retinal ganglion cells 
(AY Nakayama, Harms, and Luo 2000; Ruchhoeft et al. 1999). Expression of a dominant-negative 
RhoA conversely results in the development of significantly longer dendritic arbors in mouse 
hippocampal neurons and Xenopus optic tectal neuron when compared to controls (Ahnert-Hilger et 
al. 2004; Li, Van Aelst, and Cline 2000). It has been shown that RhoA can influence cytoskeletal 
remodeling through the activation of formin proteins, such as mDia, which directly stabilize 
microtubules and promote actin polymerization, as well as through the activation of Rho-kinase 
(ROCK), which is believed to be the primary mechanism by which RhoA prevents dendritic 
outgrowth (Lammers et al. 2008; M Amano et al. 1998; Hirose et al. 1998; Govek, Newey, and Van 
Aelst 2005). Activation of ROCK by RhoA leads to the phosphorylation and inactivation of the 
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microtubule associated proteins Tau and MAP2, potentially contributing to cytoskeleton instability 
in neuronal projections (Mutsuki Amano et al. 2003). RhoA-mediated activation of ROCK also leads 
to the phosphorylation and activation of the regulatory myosin light chain, MLC, which is believed to 
promote neurite retraction via actomyosin contraction (M Amano et al. 1998). Additionally, 
inhibition of ROCK has been shown to rescue the dendritic phenotypes that result from increased 
RhoA activity, suggesting that ROCK represents a crucial effector of RhoA in establishing dendrite 
morphology (M Amano et al. 1998; Hirose et al. 1998). Another potential mechanism by which RhoA 
prevents dendritic growth is via the inhibition of cypin, a guanine deaminase that has been shown to 
promote dendritic branching through its direct interaction with microtubules and subsequent 
facilitation of their assembly (Akum et al. 2004). Taken together, the many mechanisms by which 
RhoA mediates dendrite retraction and inhibition of dendrite outgrowth implicate it as a key 
regulator of dendrite morphology. Given the vast roles of RhoA in mediating actin and microtubule 
dynamics, further study is surely required to fully understand the role of this protein in dendrite 
development. 
 
The Rho-family GTPases Rac1 and Cdc42 have somewhat antagonistic roles to RhoA in the context of 
dendrite growth and branching. Expression of constitutively active Rac1 or Cdc42 in rat hippocampal 
neurons results in the formation of significantly longer and more highly branched dendrites when 
compared to controls (Threadgill, Bobb, and Ghosh 1997). Constitutive Rac1 activation of Rac1 
results in a similar increase in dendrite length and complexity in Xenopus retinal ganglion cells as 
well (Ruchhoeft et al. 1999). Moreover, expression of dominant negative Rac1 or Cdc42 mutants in 
both Xenopus retinal ganglion cells and mouse pyramidal neurons results in a drastic decrease in 
dendritic arbor complexity, suggesting that both of these proteins are required for dendrite 
branching during neuronal development (Ruchhoeft et al. 1999; Hayashi, Ohshima, and Mikoshiba 
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2002). Both Rac1 and Cdc42 act downstream of multiple extrinsic signaling pathways, and are crucial 
components of neurotrophin signaling during dendrite development. Following activation of the Trk 
receptors by neurotrophin ligands, which results in RhoA inhibition and Rac1/Cdc42 activation (as 
described above), Rac1 and Cdc42 go on to mediate activity of several actin and microtubule 
associated effector proteins. Both proteins activate members of the p21-activated kinase (PAK) 
family, which have been shown to induce neurite formation in PC12 cells and in cortical neurons 
(Daniels, Hall, and Bokoch 1998; M Nikolic et al. 1998). These functions of PAK proteins likely occur 
through the direct and indirect inhibition (via phosphorylation) of cytoskeleton-associated proteins 
such as cofilin and OP18. Inhibition of cofilin leads to actin polymerization and inactivation of OP18 
prevents the protein’s destabilization of microtubules, thereby increasing microtubule stability and 
growth (Maekawa et al. 1999; Sumi et al. 1999; Ohashi et al. 2000; T. Amano et al. 2001; Daub et al. 
2001; Cassimeris 2002; Wittmann, Bokoch, and Waterman-Storer 2003).  Additionally, Rac1 and 
Cdc42 both indirectly activate the Arp2/3 protein complex, which can associate with actin filaments 
and promote polymerization and ultimately dendrite branching (Eden et al. 2002; Machesky and 
Insall 1999; Rohatgi et al. 1999). This GTPase-mediated Arp2/3 activation occurs through activation 
of WASP by Cdc42 and WAVE by Rac1, with perturbation of either pathway abolishing the impact of 
Rac1 and Cdc42 activity on dendrite morphology (Tahirovic et al. 2010; Banzai et al. 2000). Taken 
together, the ability of Rac1 and Cdc42 to mediate cytoskeletal dynamics through multiple 
downstream effectors, as well as the convergence of numerous upstream pathways, each with 
known roles in dendrite elaboration, on these proteins implicates them as crucial regulators of 
dendrite development. Given the vast roles of the Rho family of GTPases, achieving a better 
understanding of their regulation during neuronal development will be a key step in revealing the 




Lastly, at the dendritic membrane, several non-receptor proteins have been shown to influence 
dendrite development, with the cadherin family of proteins having perhaps the best understood 
roles in this context. The cadherin family represents a large family (115 members) of membrane 
proteins with extensive functions in cell adhesion and signaling (Seong, Yuan, and Arikkath 2015). 
The classical cadherins are best characterized by their associations with beta-catenin and alpha-
catenin to form the cadherin-catenin complex, which serves as the primary link between the 
extracellular environment and the actin cytoskeleton of cells (Yamada et al. 2005). Members of the 
cadherin protein family each contain an extracellular cadherin (EC) domain, which is largely 
responsible for forming connections with other cells via dimerization with their respective cadherins 
(Shapiro and Weis 2009). Through their interactions with the extracellular environment, cadherins 
participate in the initiation of intracellular signaling cascades that govern cell behavior and shape 
(Seong, Yuan, and Arikkath 2015). In the context of neuronal development, N-cadherin, a classical 
cadherin first discovered in neurons, has been implicated in the outgrowth and elaboration of 
dendrites (Tan et al. 2010). Inhibition of N-cadherin’s ability to form extracellular interactions results 
in a dramatic reduction in dendrite complexity in the CA3 region of hippocampal slices (Bekirov et al. 
2008). Likewise, expression of the isolated EC domain of N-cadherin, which can bind N-cadherin of 
other cells, but fails to link the homodimer to the actin cytoskeleton, results in a similar reduction in 
overall dendrite length and branch number in cultured rat hippocampal neurons (Tan et al. 2010). 
Interestingly, loss of other members of the classical cadherin-catenin complex, such as p120-catenin, 
delta-catenin, beta-catenin, or alpha-catenin also result in atypical dendrite morphology (Tan et al. 
2010; Arikkath et al. 2008a; Elia et al. 2006; Yu and Malenka 2003). In addition to N-cadherin, 
several protocadherins (non-classical cadherin family members) have been similarly implicated in 
dendrite development. Promoting the dimerization of protocadherins in cortical neurons has been 
found to increase dendritic arbor complexity, whereas perturbing such interactions reduces 
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dendritic arbor complexity in these cells (Molumby, Keeler, and Weiner 2016). Taken together, 
these observations suggest that the cadherin family of proteins, as well as other members of the 
cadherin-catenin complex have key roles in the formation of dendritic arbors, yet much remains to 
be discovered surrounding the functions of these proteins. 
 
Summary of dendrite development: 
In summation of the pathways described here, dendrite development is an incredibly complex 
process dependent on the highly coordinated intersections of extrinsic signaling cues and intrinsic 
transcriptional and structural changes within a neuron. Prior to dendritic arbor elaboration and 
synapse formation, axon-dendrite specification occurs, which begins the specification of roles of the 
two primary types of neuronal protrusions. While this specification event is a crucial point in 
dendrite development, the work described here focuses on the morphological changes that occur 
after specification. Following axon-dendrite specification, dendrites undergo significant 
morphological changes as they develop into the iconic complex arbors that receive nearly all of the 
synaptic transmissions in the central nervous system. Despite the significance of dendrite 
morphology in the overall connectivity and function of the nervous system, much remains unknown 
about how these structures develop prior to the formation of synapses. Many of the pathways 
described above contribute to both dendrite elongation and dendrite branching, though these two 
events serve different roles in establishing neuronal connectivity and are likely mediated by distinct 
mechanisms. Developing a better understanding of the decision of a dendrite to branch or elongate, 
and how these decisions are mediated by external cues throughout development, will provide 
valuable insight into normal neuronal development and the numerous neurodevelopmental 
disorders that result from atypical dendrite morphology, and may lead to new therapeutic targets 
for these disorders. Through the work described here, I reveal a pair of novel protein-protein 
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interactions involving the p120-catenin family member, delta-catenin, that function to integrate 
external dendritic growth factors with intracellular pathways that appear to converge on actin 
regulatory proteins and ultimately contribute to the countless elongation and branching events that 




p120-catenin protein subfamily: 
Catenins are a family of proteins, most famously known for their interactions with classical 
cadherins as part of the catenin-cadherin complex (Shapiro and Weis 2009). The p120-catenin 
subfamily of catenins contains four members: p120-catenin, ARVCF catenin, p0071, and delta-
catenin, all of which possess diverse roles in the development of the nervous system and other 
tissues (McCrea and Park 2007). Like most catenins, members of the p120-catenin family contain a 
series (usually 9 to 12) of ARM repeats, which comprise the Armadillo domains of these proteins 
(Figure 2). These ARM repeats, about 42 amino acids in length, each contain three alpha helices that 
fold into a super-helix of helices to form the larger Armadillo domain (Huber, Nelson, and Weis 
1997; Anastasiadis and Reynolds 2000). The Armadillo domains of catenins are responsible for 
interactions with cadherin proteins found in all tissues and are central to many of the adhesive and 
signal transduction roles of these proteins. In the case of the p120-catenin subfamily, the Armadillo 
domain functions to stabilize cadherins at the membrane and prevent their endocytosis, thereby 
regulating the adhesive behaviors of the cell (Davis, Ireton, and Reynolds 2003; Kowalczyk and 
Reynolds 2004). In addition to their shared Armadillo domains, three members of the p120-catenin 
family, ARVCF-catenin, p0071-catenin, and delta-catenin, each contain a PDZ-binding motif at their 
C-terminus, which is capable of interacting with the PDZ domains of many proteins important for 
the signaling events in various tissues during development (McCrea and Park 2007). These PDZ-
dependent interactions have diverse roles in development, ranging from stabilization of structures 
such as synapses, to regulation of subcellular localization and transcriptional activity of the catenin 
proteins (Arikkath et al. 2008b; Kausalya, Phua, and Hunziker 2004; Ide et al. 1999). Lastly, along 
with mediating cell adhesion through associations with the cadherins, many catenin proteins, 






Figure 2. Schematic of members of the p120-catenin subfamily of proteins. 
 
The p120-catenin subfamily includes delta-catenin, ARVCF, p0071, and p120-catenin. Each member 
contains a central ARM domain composed of Armadillo repeats, enabling the protein to form 
interactions with adhesion proteins, such as the cadherins. Unlike p120-catenin, delta-catenin, 
ARVCF, and p0071 contain a PDZ-binding motif at their respective C-termini that allows them to 





pathway previously implicated in both dendrite and axon development (Rosso et al. 2005; Bian et al. 
2014; Ferrari et al. 2018; McCrea and Park 2007).  
 
The namesake of this family, p120-catenin, is crucial for embryogenesis, with knockout of p120-
catenin in mice resulting in embryonic lethality (Davis and Reynolds 2006). While many of the 
developmental roles of p120-catenin stem from its maintenance of membrane cadherins, it has also 
been shown to be a key regulator of Rho-family GTPase activity. P120-catenin activates Rac1 and 
Cdc42, and contributes to the recruitment of active Rac1 to cadherin-mediated cellular junctions 
(Noren et al. 2000; Grosheva et al. 2001). P120-catenin also directly interacts with and inhibits RhoA 
activity by blocking the GDP-GTP exchange of RhoA (Anastasiadis et al. 2000). Finally, p120-catenin 
is also known to function as a transcriptional regulator in the nucleus, where it directly interacts 
with the transcriptional repressor Kaiso and relieves the repression of its target genes (Daniel and 
Reynolds 1999; J.-I. Park et al. 2005). In conditional knockout models, p120-catenin was 
demonstrated to be required for the development and maintenance of epithelial tissues such as 
vertebrate skin, in which p120-catenin’s stabilization of cadherins contributes to barrier function 
and junction stability, and in cardiovascular tissues, where its stabilization of cadherins is crucial for 
vascular integrity and endothelial cell proliferation (Perez-Moreno et al. 2006; Xiao et al. 2003; Oas 
et al. 2010). P120-catenin has also been implicated as a potential oncogene, as it has been shown to 
induce increased metastasis and tumor growth in certain breast cancers (Soto et al. 2008; Reynolds 
et al. 1994). This is believed to occur through either the stabilization of mesenchymal cadherins, 
activation of Rho-family GTPases, or through association with the transcriptional repressor Kaiso in 
the nuclei of cancer cells, as all of these mechanisms have been linked to tumor growth and invasion 
(Soto et al. 2008; Reynolds et al. 1994; Jones et al. 2012; Vermeulen et al. 2012). In the nervous 
system, p120-catenin has been found to influence dendritic spine development, and loss of p120-
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catenin in mouse hippocampal neurons results in a reduced amount of dendritic spines and 
synapses along dendrites in these cells. It is believed that this function of p120-catenin occurs 
through the combination of stabilization of neuronal cadherins, activation of Rac1, and inactivation 
of RhoA in developing dendrites. (Elia et al. 2006). 
 
While less understood than their catenin relatives, ARVCF-catenin and p0071-catenin both have 
established roles in adherens junction formation and vertebrate development. Notably, loss of 
ARVCF-catenin has been strongly linked to Velo-Cardio-Facial syndrome (VCFS), a developmental 
disorder resulting in craniofacial and cardiovascular defects in humans (Sirotkin et al. 1997). ARVCF-
catenin depletion in Xenopus embryos results in gastrulation defects, likely stemming from the 
protein’s modulation of Rho-family GTPases and cadherin stability, as expression of dominant-
negative RhoA, constitutively active Rac1, or overexpression of C-cadherin can rescue these defects 
(Fang et al. 2004). The roles of p0071-catenin, on the other hand, are not nearly as well understood 
as those of its relatives, though the protein has been found to function in the activation of RhoA 
during cytokinesis, with loss of p0071-catenin resulting in the induction of apoptosis during this 
process (Keil et al. 2007). Given the roles of p0071-catenin in cellular processes, it will be interesting 
to reveal the developmental roles of this protein, though much additional work is required in this 
area. Lastly, the final member of the p120-catenin family, delta-catenin, has roles in development 
mostly exclusive to the central nervous system, and will be described in detail in the following 
section, as it is the primary focus of this work. Overall, members of the p120-catenin family of 
proteins have diverse and crucial functions throughout vertebrate development. In many cases, 
these proteins act as key regulators of cell signaling and tissue specification, making further study of 





Of the p120-catenin protein subfamily, delta-catenin has the most well-established roles in the 
central nervous system, and its expression is almost entirely localized to this region (Ho et al. 2000). 
Delta-catenin is a 150kD protein that, as previously mentioned contains an Armadillo domain 
composed of ARM repeats, as well as a C-terminal PDZ-binding motif. The Armadillo domain of 
delta-catenin binds to N-cadherin, as it does to several other proteins important for neural 
development and function (Gu et al. 2009; Yuan et al. 2015). The PDZ-binding motif of delta-catenin 
is a highly-conserved region (General: xSxV; delta-catenin: DSWV) at its C-terminus that can 
recognize and bind several PDZ domain-containing proteins crucial for neural development (Yuan et 
al. 2015). Most notably, the PDZ-binding motif of delta-catenin interacts with the PDZ proteins Erbin 
and Magi2/S-SCAM, which are necessary for dendrite extension/branching and synapse 
development, respectively (Arikkath et al. 2008b; Ide et al. 1999). Interestingly, proteomic analysis 
of the developing rat brain has revealed a pair of phosphorylation sites (S1245 and S1242) within 
the PDZ-binding motif of delta-catenin, although the function of these phosphorylation events 
remains unknown (Lundby et al. 2012). Nevertheless, there is precedence for the importance of 
these phosphorylation sites, as catenin proteins are known to be targets of post-translational 
modifications that alter their functional properties (Gottardi and Gumbiner 2004). 
 
As briefly mentioned above, delta-catenin is highly expressed in the central nervous system 
throughout development and into adulthood (Ho et al. 2000). Like the other p120-catenin family 
members, delta-catenin has both structural and signaling roles within cells, and functions in many 
facets of cell development, particularly in the development of cells within the central nervous 
system. Namely, a delta-catenin knockout mouse model develops cognitive deficits (primarily in 
learning and memory) and has severe defects in dendritic morphology, as well as synaptic plasticity, 
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demonstrating the roles of delta-catenin in early brain development and beyond (Israely et al. 2004; 
Matter et al. 2009). In both hippocampal neuron cultures and in vivo, delta-catenin has been shown 
to regulate both dendrite elongation and branching during development, with these functions being 
believed to occur via dynamic modulation of the GTPases Rac1, Cdc42, and RhoA, resulting in 
downstream alterations in the actin cytoskeleton (Martinez et al. 2003). Additionally, in neuronal 
cultures, delta-catenin has been shown to be required for normal dendrite development, with 
shRNA-mediated knockdown of delta-catenin leading to inhibition of both dendrite elongation and 
branching (Arikkath et al. 2008a; Martinez et al. 2003). Moreover, overexpression of delta-catenin in 
NIH 3T3 cells, as well as in other non-neuronal cells, leads to the formation and branching of 
dendrite-like processes, which has been linked to the remodeling of actin and microtubules (H. Kim, 
Han, et al. 2008; K. Kim et al. 2002). Lastly, delta-catenin has been implicated in several 
neurodevelopmental disorders, with perturbations in the protein’s normal functioning being 
associated with cognitive disorders such as cri-du-chat syndrome, autism, and schizophrenia 
(Medina et al. 2000; Turner et al. 2015; Vrijenhoek et al. 2008). These roles of delta-catenin position 
it to be a key regulator of neuron development, specifically in the context of dendritic arbor 
formation. Developing a better understanding of how delta-catenin contributes to both dendrite 
elongation and branching will provide new avenues for research into neuronal development and 
potentially into new therapeutic targets for several neurodevelopmental diseases. 
 
 
MAGUK protein family, Magi1, and Pdlim5: 
The Membrane-Associated Guanylate Kinase (MAGUK) family of proteins represents a large group of 
proteins with both scaffolding and signaling roles in cellular function. Members of this family contain 
at least one PDZ (PSD-95, DLG, ZO-1) domain, a Src Homology 3 (SH3) domain, and an inactive 
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Guanylate Kinase (GK) domain (Oliva et al. 2012). The PDZ domain of these proteins are typically 80-
100 amino acids in length and are composed of six beta-sheets, one long alpha-helix, and one short-
alpha helix, with the beta-sheets and long alpha-helix forming a binding pocket for PDZ-binding 
motifs, like the one found in delta-catenin (H. J. Lee and Zheng 2010). These PDZ domains are 
required for many of the functions of MAGUK proteins, and represent key points of regulation in 
many pathways. Notably, the Wnt signaling pathway described above, which contributes to dendrite 
elaboration, is dependent on the PDZ domains of Disheveled, a PDZ domain-containing scaffold 
protein that functions downstream of Wnt7b signaling (Rosso et al. 2005). Arguably the best studied 
members of the MAGUK family are the Zona Occludens proteins (ZO-1, ZO-2, and ZO-3) and 
postsynaptic density protein 95 (PSD-95), all of which have crucial roles at cell junctions. The Zona 
Occludens proteins have three PDZ domains, each of which are required for the formation and 
function of tight junctions through the recruitment of transmembrane claudins proteins (Umeda et 
al. 2006). PSD-95 similarly functions in the assembly and maintenance of cell junctions via 
interactions with its PDZ domains, though largely in the context of synapses in the nervous system. 
PSD-95 is highly localized to the post-synaptic density, where it is important for the stabilization and 
organization of several proteins, such as NMDA and AMPA receptors (Kornau et al. 1995; Bats, Groc, 
and Choquet 2007). Because of this, PSD-95 acts as a key regulator of synaptic strength and 
remodeling, and is crucial for synapse formation (Bats, Groc, and Choquet 2007; X. Chen et al. 2015, 
2011). Taken together, members of the MAGUK family of proteins have established roles in the 
function and organization of protein complexes found at the cell membrane and at cellular 
junctions. The importance of MAGUK proteins’ PDZ domains for many of their functions in 
membrane signaling warrants further research into the potential significance of these domains in 
other areas of biology, particularly dendrite development, as this process is highly dependent on the 




Magi1 is a neural member of the membrane-associated guanylate kinase, or MAGUK, subfamily of 
PDZ proteins. Magi1 contains six PDZ domains, a GUK domain, and two WW motifs (Figure 3). Like 
its relatives, Magi1 has been implicated in synaptic maintenance, in which it is believed to act as a 
scaffold for the transmembrane adhesion protein, Sidekick-2 (Yamagata and Sanes 2010). However, 
most previous studies on Magi1 have focused on non-neuronal tissues, where it functions as a 
scaffold at cellular junctions of epithelial cells, as well as acting as a tumor suppressor 
(Dobrosotskaya and James 2000). Recently, a Magi1 knockout mouse has been developed to 
investigate the roles of this protein in the cardiovascular system, and has revealed potential roles for 
the protein in stress-mediated responses of endothelial cells in cardiac tissues (Abe et al. 2019). 
While the neurological effects of Magi1 loss in vivo have yet to be investigated, given the effects 
observed in vitro, described below, it will be interesting to see if these mice develop cognitive 
anomalies in response to Magi1 loss. In primary rat dorsal root ganglion cell cultures, Magi1 localizes 
to the growth cones of developing neurites, while in PC12 rat pheochromocytoma cells, RNAi-
mediated knockdown of Magi1 leads to a loss of nerve growth factor (NGF)-induced neurite 
outgrowth (Ito et al. 2013). Magi1 copy number variation has also been associated with both bipolar 
disorder and schizophrenia, providing further evidence of the protein’s significance in neuronal 






Figure 3. Schematic of Magi1 and other members of the MAGUK protein family.  
 
Magi1 contains six PDZ domains, lending to its function as a scaffold protein, as well as a pair of WW 
domains. Magi1, Magi2, and Magi3 share a similar protein domain schematic, but have surprisingly 
low homology and fulfill different functions in various tissues. PSD-95 is a MAGUK protein family 
member with well-established roles as a synaptic scaffolding protein.   
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findings on the involvement of Magi1 in neurite extension, the mechanisms underlying the protein’s 
role in dendritogenesis remain unclear. 
 
Pdlim5 
Pdlim5, like Magi1, is a PDZ protein that has enriched expression in neural tissues. While not a 
member of the MAGUK protein family, it contains one PDZ domain and three LIM (Lin11, Isl-1 & 
Mec-3) domains, each enabling protein-protein interactions relevant to neural development (Figure 
4). Pdlim5 has been suggested to function in the restriction of dendritic spine growth through an 
interaction with Spine Associated RapGAP (SPAR) via the LIM2/3 domain of Pdlim5 (Herrick et al. 
2010). While not much is known about protein interactions with the PDZ domain of Pdlim5, it has 
been shown to interact with the actin-binding protein alpha-actinin in cardiomyocytes, and is crucial 
for heart development (Nakagawa et al. 2000). While homozygous knockout of Pdlim5 is lethal in 
mouse models, largely due to embryonic heart failure, a heterozygous loss of the protein results in 
significantly increased immobility in forced swim tasks, a behavior often linked to depression 
(Horiuchi et al. 2013). Further, administration of antidepressents in mice has been shown to result in 
increased Pdlim5 expression in the hippocampus, suggesting a role for this protein in network 
remodeling (Horiuchi et al. 2013). Additionally, like Magi1, Pdlim5 localizes to the growth cones of 
neurite tips in primary neuron cultures. However, while Magi1 is thought to contribute to neurite 
outgrowth, Pdlim5 has been found to promote growth cone collapse via the translocation of PKCε to 
the membrane (Ren et al. 2015). In line with in vivo results from mouse models, Pdlim5 has also 
been implicated in the progression of several neurological conditions, including schizophrenia, 
bipolar disorder, and major depression, although its role in the onset of these maladies remains 













Figure 4. Schematic of Pdlim protein family.  
 
All Pdlim proteins contain a single N-terminal PDZ domain, and at least one C-terminal LIM domain. 
Pdlim proteins 1-4 contain only a single LIM domain, whereas Pdlim5, Pdlim6, and Pdlim7 each 














Part One: Identification of novel phospho-dependent interactions formed by delta-catenin 
 
Identification of phosphorylation sites in the PDZ-binding motif of delta-catenin: 
Given the numerous roles of delta-catenin in neuronal development, I sought to identify novel 
partners of delta-catenin that might help explain the function of delta-catenin in the elaboration of 
dendrite morphology. Based upon the literature, delta-catenin interacts with several PDZ domain-
containing proteins, among others, during neuronal development (Yuan et al. 2015; Ide et al. 1999; 
Arikkath et al. 2008a). These interactions are entirely dependent on the PDZ-binding motif of delta-
catenin, which is present at the protein’s extreme C-terminus. Analysis of this region reveals a 100% 
conserved identity across multiple species (human, mouse, rat, chicken, frog, and fish). This suggests 
that the PDZ-binding motif of delta-catenin plays a crucial role in the protein’s function. Further, the 
closest relative to delta-catenin (CTNND2), p120-catenin (CTNND1), lacks this motif, providing 
further evidence that this region gives rise to roles and functions unique to delta-catenin. I noticed 
that the PDZ-binding motif of delta-catenin contains two conserved phospho-serines at its extreme 
carboxyl-terminus (e.g. mouse S1242 and S1245) (Figure 5), that importantly have been observed to 
be phosphorylated in vivo (Lundby et al. 2012). Please note that to enable me to speak in a uniform 
way about these residues across species, I refer to them as being at the -6 and -3 positions (w/ the -





Figure 5. Conservation of the C-terminus of delta-catenin across species.  
 
The PDZ-binding motif of delta-catenin is fully conserved across human, mouse, rat, chicken, frog, 
and fish. This region contains a pair of phosphorylation sites at S1245 (-3) and S1242 (-6) that are 




Delta-catenin interacts with Magi1 and Pdlim5 in a phospho-dependent manner: 
In other published examples, phosphorylation events within a PDZ-binding motif can alter the ability 
of the motif to bind partner proteins (H. J. Lee and Zheng 2010; Chung et al. 2000; A. B. Espejo et al. 
2017). I chose to utilize protein-domain microarrays to help reveal novel PDZ-domain proteins that 
bind to delta’s PDZ-binding motif, and to test if phosphorylation at the -6 and/ or -3 serine positions 
of delta has an impact upon such interactions. Such arrays excel at revealing the importance of post-
translational modifications, such as phosphorylation events, in the modulation of protein-protein 
interactions. To obtain a read-out of relative binding levels, 98 individually purified PDZ-domains 
that had demonstrated peptide binding activity to PDZ binding motifs (Stiffler et al. 2006), from 68 
different human proteins, were arrayed by the MDACC Protein Array and Analysis core facility 
(Director: Mark T. Bedford, Ph.D.), and probed with biotinylated unphosphorylated versus 
phosphorylated delta-catenin peptides inclusive of its PDZ-binding motif (Figure 6A). The data 
pointed to a number of interactions, including positive controls that had been expected (e.g. Erbin 
and Magi2; (Ide et al. 1999; Arikkath et al. 2008a)). Given my interest in potential phospho-
regulation of delta’s PDZ-binding motif, I focused upon a novel pair of phospho-regulated 
interactions that were revealed, namely with a PDZ-domain present in Magi1, and another in 
Pdlim5, both of which are expressed in the mammalian central nervous system (Karlsson et al. 2012; 
Kato et al. 2005). Using the PDZ-domain microarrays, it was found that the unphosphorylated probe 
inclusive of delta’s PDZ-binding motif bound to the final PDZ domain (PDZ5) of Magi1 (pair of circled 
green spots), whereas the phosphorylated probe lost most such association. These results are 
consistent with earlier experiments performed by the McCrea Lab using yeast two hybrid screens 
with delta-catenin as bait against a rat brain cDNA library. Two independent clones of Magi1 
containing the same PDZ5 domain were identified as potential interaction partners of delta-catenin 
(screen performed by Hybrigenics Inc.; results not shown). Importantly, the PDZ-domain microarrays 
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revealed the opposite phospho-dependent behavior for the lone PDZ domain present within Pdlim5 
(Figure 6B). While several other proteins displayed PDZ domains able to bind delta’s phosphorylated 
PDZ-binding motif in vitro (e.g. Erbin), Pdlim5 was the only target observed to require the PDZ-
binding motif of delta-catenin to be phosphorylated in order for an interaction to occur.  
 
To assess the independent importance of each of the phosphorylation sites in delta-catenin’s PDZ-
binding motif (-6 and -3 serines) for the interaction with Pdlim5, the PDZ-domain microarray was 
repeated using peptides phosphorylated at only one of the two serines present. I found that delta-
catenin’s PDZ-binding motif binds best to Pdlim5 when both the -6 and -3 serines of delta are 
phosphorylated, although phosphorylation of even a single serine in this motif promotes this 
interaction (white paired spots indicate higher association that green) (Figure 6C). Likewise, 
phosphorylation at either the -6 or -3 serine interrupts any potential interaction with Magi1. This 
switch-like modulation of associations with neural interaction partners hinted that delta-catenin 
























A: Erbin PDZ   E: OMP25 PDZ   H: SAP102 PDZ (2/3) 
B: Lrrc7 PDZ   F: NHERF-2 PDZ  I: ZO-1 PDZ (1/3) 
C: Interleukin 16 PDZ (1/4) G: PTP-BL PDZ (2/5)  J: SLIM PDZ 







Figure 6. Protein domain microarray reveals that delta-catenin interacts with Magi1 and Pdlim5 in a 
phospho-dependent manner. (Data collected by and used with the permission of Mark T. Bedford, 
PhD and Cari Sagum - MD Anderson Cancer Center) 
 
A, Schematic of a protein-domain microarray. A comprehensive library of PDZ domain peptides on a 
microplate were probed with either phosphorylated or unphosphorylated biotinylated delta-catenin 
PDZ-binding motif peptides. B, Phosphorylation of the PDZ-binding motif of delta-catenin modulates 
the protein’s ability to interact with several partner proteins. Magi1 is bound by the 
unphosphorylated motif, but not by the phosphorylated motif (blue). Pdlim5 is only bound by the 
phosphorylated delta-catenin PDZ-binding motif (red). C, Phosphorylation at either serine in the 
PDZ-binding motif of delta-catenin is sufficient to allow interaction with Pdlim5. Phosphorylation at 






Validation of Protein Domain Microarray results: 
The phospho-dependency of these interactions was further validated in cells using a method I 
developed to visualize protein-protein associations within intact cells and refer to as the Golgi Co-
Relocalization Assay (GRA). GRA relies on relocalizing a protein of interest, in this case delta-catenin, 
to the outer membrane surface of the Golgi, enabling one to see if putative partner proteins 
become co-relocalized, indicating an association between the two proteins. I found traditional 
protein interaction detection methods, such as co-immunoprecipitation, to be inconsistent in 
detecting these PDZ domain-dependent interactions. After learning of similar issues in other labs, 
including those who study validated PDZ domain-dependent interactions with delta-catenin, it 
seemed that cell lysis disrupting these associations was the most likely culprit. Since GLA avoids the 
harsh conditions of cell lysis, the assay is much better suited to detect weak or transient 
interactions, such as those studied in this work. The GLA assay I developed was able to more 
consistently detect published PDZ domain-dependent interactions (Example: delta-catenin:Magi2 
(Ide et al. 1999)) than traditional methods, such as co-immunoprecipitation, and therefore became 
the method of choice for observing these interactions for the remainder of this work. 
 
To probe both the phospho- and phospho-null states of the PDZ-binding motif of delta-catenin, I 
utilized point mutants in which both of delta-catenin’s -6 and -3 serines (mouse S1242, S1245) were 
replaced either with glutamate (phospho-mimic) or with alanine (phospho-null). Using HEK293 cells, 
which lack endogenous delta-catenin, exogenous phospho-null or phospho-mimic delta-catenin was 
expressed and directed to the Golgi. When expressing phospho-null delta-catenin, I observed that 
co-expressed Magi1 co-relocalized to the Golgi from the cell cytosol and membrane (Figure 7). This 
same phospho-null delta-catenin construct failed to co-relocalize co-expressed Pdlim5, which 
remained in the cytosol and at the cell membrane (Figure 8). Conversely, when a phospho-mimic 
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delta-catenin was directed to the Golgi, Magi1 failed to co-relocalize, whereas Pdlim5 succeeded in 
co-relocalizing to the Golgi with delta-catenin, indicating the presence of an interaction. Thus, my in-
cell GRA findings support the same binding selectivity suggested from the in vitro protein-domain 
microarrays. They also provide some confidence, in combination with later findings, that these 
delta-catenin point mutants adequately mimic the phosphorylated versus dephosphorylated forms 
of delta’s PDZ-binding motif in the context of protein binding behavior. 
 
I also opted to further validate the results of the protein domain microarray, which suggest that 
delta-catenin specifically binds the PDZ5 domain of Magi1 and the sole PDZ domain of Pdlim5. This 
was accomplished by mapping the regions of Magi1 and Pdlim5 required to bind delta-catenin, via a 
series of deletions within each protein, and using my Golgi Co-relocalization Assay as a readout 
(Figure 9 and 10). As expected, my findings further supported the microarray results, since the sole 
PDZ domain of Pdlim5, as well as the PDZ5 domain of Magi1, were required for the respective 
interaction and co-relocalization of Pdlim5 and Magi1 with delta-catenin. Interestingly, deletion of 
the PDZ domain of Pdlim5 induced nuclear translocation of the protein, although the significance of 






Figure 7. Validation of phospho-dependency for Magi1:delta-catenin interaction via Golgi Co-
relocalization assay.  
 
Mutant delta-catenin constructs (red) with phospho-null properties (S1242A, S1245A) or phospho-
mimic properties (S1242E, S1245E) were expressed in HEK293 cells and relocalized to the Golgi 
body. Magi1 (green) co-relocalizes to the Golgi with phospho-null delta-catenin but not phospho-






Figure 8. Validation of phospho-dependency for Pdlim5:delta-catenin interaction via Golgi Co-
relocalization assay.  
 
Mutant delta-catenin constructs (red) with phospho-null properties (S1242A, S1245A) or phospho-
mimic properties (S1242E, S1245E) were expressed in HEK293 cells and relocalized to the Golgi 
body. Pdlim5 (green) co-relocalizes to the Golgi with phospho-mimic delta-catenin but not phospho-
null delta-catenin (red), indicating an interaction specificity for unphosphorylated delta-catenin, 









































Figure 9. Delta-catenin interacts with the c-terminal PDZ domain of Magi1.  
 
The protein-domain microarray data was further validated using domain mapping of Magi1 in 
combination with a Golgi Co-relocalization assay in HEK293 cells. A-D, Mapping of PDZ domain(s) of 
Magi1 required for interaction with delta-catenin. A, Full-length Magi1 (green) co-relocalizes with 
delta-catenin (red) to Golgi body. B, Deletion of PDZ4 and PDZ5 of Magi1 renders the protein unable 
to interact with delta-catenin, thereby preventing co-relocalization of Magi1 with delta-catenin (red) 
to the Golgi body. C, Deletion of only PDZ5 of Magi1 also renders Magi1 (green) unable to co-
relocalize to the Golgi, suggesting that PDZ5 is required for Magi1’s interaction with delta-catenin. 



























Figure 10. Delta-catenin interacts with the sole PDZ domain of Pdlim5.  
 
The protein-domain microarray data was further validated using domain mapping of Pdlim5 in 
combination with a Golgi Co-relocalization assay in HEK293 cells. A-B, Validation and mapping of 
Pdlim5:delta-catenin interaction. A, Full-length Pdlim5 co-relocalizes with delta-catenin to Golgi 
body. B, Deletion of the PDZ domain in Pdlim5 renders the protein unable to interact and co-





Part Two: Characterization of delta-catenin, Magi1 and Pdlim5 in neuron development 
 
Spatial and temporal expression of delta-catenin, Magi1, and Pdlim5 in hippocampal neurons: 
Based on available data, I was aware that delta-catenin, Magi1, and Pdlim5 are each expressed in 
the mammalian central nervous system, however, a more detailed analysis of the expression pattern 
of these proteins in developing neurons was needed (Ito et al. 2012; Ren et al. 2015). Through the 
use of confocal microscopy, I observed that delta-catenin, Magi1, and Pdlim5 are each expressed in 
hippocampal neurons during dendrite development.  
 
I employed a rat primary hippocampal neuron culture model, as it is established in studies of 
mammalian neuron development (Dotti, Sullivan, and Banker 1988; Kaech and Banker 2006). Early 
in neuron development (1DIV), delta-catenin, Pdlim5, and Magi1 are expressed comparable levels, 
with the amount of Magi1 relative to delta-catenin and Pdlim5 decreasing significantly as neurons 
mature (28DIV). At 1DIV (days in vitro), delta-catenin is ubiquitously expressed in hippocampal 
neurons. Magi1 appeared to be enriched in the soma of these neurons, with expression extending 
into the bases of newly forming neurites (future dendrites). Conversely, at 1DIV, Pdlim5 is expressed 
primarily in these protrusions and is enriched at their tips (Figure 11). By 7DIV, delta-catenin 
continues to be ubiquitously expressed, with Magi1 and Pdlim5 having enriched localization to the 
dendrites. Specifically, at 7DIV, Magi1 protein appears to be highly enriched at the tips of dendrites, 
with lower amounts present elsewhere in dendrites and soma. Pdlim5 is also present in the soma 
but enriched in dendrites, with the highest visualization in dendrite tips. In mature hippocampal 
neurons (28DIV), both delta-catenin and Pdlim5 protein are still present in dendrites, whereas 
Magi1 expression/localization is lessened, in line with reduced dendrite extension by this point in 
development. The coordinate presence of delta-catenin, Magi1, and Pdlim5 throughout much of 
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hippocampal in vitro development, and my resolution of the delta:Magi1 and delta:Pdlim5 protein 
complexes (see also below), supports the potential contribution of these interactions to 
dendritogenesis. 
 
Through the use of super-resolution confocal microscopy (STORM), I found that both Magi1 (Figure 
12) and Pdlim5 (Figure 13) localize to punctated and potentially distinct filopodial-like structures 
along dendrites of hippocampal neurons (4DIV). Via STORM, delta-catenin appears at the base of 
these delta:Magi1 and delta:Pdlim5 structures, as well as within the lengths of dendrites. While both 
the Magi1 and Pdlim5 enriched structures occur along the length of dendrites, the Magi1 intensities 
appear more evident towards dendritic tips (White arrows, Figure 12). Given the potential detail 
that can be revealed with STORM imaging, a separate study will be needed to fully examine the 
delta:Magi1 and delta:Pdlim5 complexes in relationship to cytoskeletal and other associated 
proteins. Additionally, further examination of the properties of these filopodia-like structures will be 
required to fully discern their roles in the biology of neurons. Nevertheless, my findings from STORM 







Figure 11. Distribution of delta-catenin, Magi1, and Pdlim5 during hippocampal neuron 
development. 
 
Expression of delta-catenin (green), Magi1 (red-top), and Pdlim5 (red-bottom) in developing primary 
rat hippocampal neurons at 1DIV, 7DIV, and 28DIV. Delta-catenin (green) is ubiquitously expressed 
in hippocampal neurons throughout development. Magi1 (red-top) localizes to neurite extensions 
by 1DIV (top-left) and becomes further enriched at dendritic tips at 7DIV (top-center). Magi1 
expression becomes reduced by the time of neuronal maturation at 28DIV, though is still present in 
the dendrites and soma (top-right). Pdlim5 (red-bottom) localizes to neurite protrusions as early as 
1DIV (bottom-left), and becomes highly enriched near the dendritic tips by 7DIV (bottom-center). 
Pdlim5 remains enriched in the axon/dendrites through neuronal maturity at 28DIV (bottom-right). 




Figure 12. Magi1 localizes to puncta near the tips of developing dendrites. 
 
Super-resolution imaging (STORM) of Magi1 (green) and delta-catenin (red) reveals that Magi1 
localizes in a punctated manner to the tips of dendrites in filopodia-like structures (white arrows), 
while delta-catenin is mostly ubiquitously expressed along the dendrite, though becomes enriched 





Figure 13. Pdlim5 localizes to puncta along the length of developing dendrites. 
 
Super-resolution imaging (STORM) of Pdlim5 (green) and delta-catenin (red) shows that Pdlim5 
localizes along the length of dendrites to filipodia-like structures, while delta-catenin appears to 





Delta-catenin interacts with Magi1 and Pdlim5 during hippocampal neuron development: 
To assess whether endogenous delta-catenin interacts in primary rat hippocampal neurons with 
endogenous Magi1 and Pdlim5, I utilized a proximity ligation assay (PLA) (Duolink). This method 
detects direct or closely apposing interactions (Söderberg et al. 2006). I opted to use PLA to further 
validate the existence of these interactions for two primary reasons. First, my Golgi co-relocalization 
assay relies on the exogenous expression of proteins in established cell lines, whereas PLA can 
detect interactions between endogenous proteins, without the need to lyse cells, as required in the 
case of co-immunoprecipitation, which can also detect interactions between endogenous proteins. 
Second, PLA has the ability to reveal direct interactions in primary neuronal cultures, a key 
observation required to establish the significance of protein complexes in neuron development and 
function. 
 
At 7DIV, hippocampal cultures exhibited significantly more PLA puncta for the delta-catenin:Magi1 
and delta-catenin:Pdlim5 complexes than in negative controls (delta-catenin:c-Jun) (Figure 14). 
Puncta were substantially localized along dendrites, supporting the presence of these complexes in 
developing neurons. It is worth noting that it is difficult to extract information on precise localization 
of protein complexes using PLA, and the method is best suited for the detection of direct 
interactions and the general localization of such associations. Regardless, my PLA findings in 
common with STORM observations support delta-catenin’s direct endogenous interactions with 





Figure 14. Delta-catenin interacts with endogenous Magi1 and Pdlim5 in hippocampal neurons. 
 
Detection of direct associations between delta-catenin and the proteins Magi1 and Pdlim5 in 
developing hippocampal neurons. A Proximity Ligation Assay (Duolink), in combination with delta-
catenin, Magi1, and Pdlim5 antibodies, was used to detect direct protein-protein interactions in 
7DIV hippocampal neurons. A, Visualization of Magi1:delta-catenin (left) and Pdlim5:delta-catenin 
(center) interactions, as detected by the presence of red puncta. Antibodies specific to delta-catenin 
and c-Jun were used in a negative control assay (right). B, Quantification of average puncta per 
neuron in each condition (delta-catenin+ Magi1: 16.01 (p=0.0159); Pdlim5: 37.73 (p=0.0007); c-





Delta-catenin contributes to the in vitro morphogenesis of hippocampal neurons: 
Given the reported roles of delta-catenin in neuronal development and dendrite morphology, I 
aimed to address mechanisms by which this protein functions in neurons. To address the neuronal 
roles of delta-catenin, a primary rat hippocampal neuron culture model was used. Primary rat 
hippocampal neurons were transfected at 3 days in vitro (DIV) and fixed at 7DIV. The rationale for 
choosing 7DIV as my assay stop-point is that at 7DIV the dendritic tree is already quite complex, yet 
very few synapses have started to form. This enabled me to address impacts on dendrite 
morphology prior to synaptic changes becoming an additional driving force behind observed 
alterations. However, given the roles of these proteins described in this work, all three may very 
well function in synaptogenesis, synaptic maintenance, and post-developmental dendritic 
maintenance. Therefore, it will be very interesting to study the roles of delta-catenin, Magi1, and 
Pdlim5 beyond early dendrite development, as they may likely contribute to neuronal connectivity 
via multiple interconnected mechanisms, in addition to those described in this work. 
 
In developing neurons experiencing shRNA-mediated knockdown of delta-catenin beginning at 3DIV 
(using a previously published delta-catenin shRNA sequence (Arikkath et al. 2008a)), the dendritic 
tree was much more restricted when compared to control neurons at 7DIV (Figure 15). Validation of 
shRNA-mediated knockdown of delta-catenin revealed a near complete loss of delta-catentin in 
HEK293 cells (Figure 16). While dendrite lengths were significantly reduced, the overall number of 
dendrites was left relatively unchanged, suggesting that delta-catenin may not be essential for early 
dendritogenesis, but rather dendritic tree elaboration (extension/branching of existing dendrites). 
Conversely, when delta-catenin was exogenously overexpressed (initiated at 3DIV), dendritic trees 
showed significant increases in complexity as well as length compared to controls by 7DIV (Figure 
15). These overexpression findings support the notion that expression of delta-catenin is sufficient 
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to drive the elaboration of dendritic arborizations in developing neurons. Together, these results 
(knockdown and overexpression of delta-catenin) support prior studies that dendrite branching and 
elongation is modulated by delta-catenin (Arikkath et al. 2008b; Martinez et al. 2003). 
 
Magi1 contributes to dendrite extension during neuronal development: 
I next sought to elaborate on the known neuronal functions of Magi1, and utilized the same primary 
neuron culture model as previously described for the work on delta-catenin. Neurons 
overexpressing Magi1 developed significantly longer dendrites when compared to controls, whereas 
dendrite density (number of tips) was not significantly changed (Figure 17). In addition to 
overexpression of Magi1, I utilized shRNA-mediated knockdowns beginning at 3DIV with fixation 
done at 7DIV. This allowed me to observe how dendrites develop with reduced levels of Magi1. 
Unlike with delta-catenin, a previously published shRNA sequence targeting Magi1 did not exist. In 
order to knockdown Magi1 in neurons, I screened several predicted hairpin sequences capable of 
preventing Magi1 translation in neurons using the siRNA Wizard v3.1 tool (InvivoGen), and validated 
the knockdown efficiency of these sequences until one was observed to produce a sufficient 
knockdown of Magi1 in HEK293 cells (Figure 18). All sequences generated were compared to rat, 
mouse, and human Magi1 in order to produce a single shRNA sequence hopefully capable of 
knocking down protein expression in cells from each of these organisms. Consistent with my over-
expression results, knock-down of Magi1 in developing hippocampal neurons significantly decreased 
average dendrite lengths (Figure 17B). Interestingly, similar to overexpression of Magi1, neurons 
exhibiting reduces levels of the protein did not have significant changes in overall dendrite density. 
These results suggest that Magi1 plays a role in dendrite elongation rather than dendrite branching 














Figure 15. Delta-catenin plays a major role in the establishment of hippocampal neuron dendrite 
morphology.  
 
Primary rat hippocampal cultures were transfected at 3DIV and imaged at 7DIV to quantify dendritic 
morphology. A, representative images of 7DIV rat hippocampal neurons expressing GFP, delta-
catenin cDNA, and delta-catenin shRNA. B, Quantification of average dendrite length of neurons 
expressing GFP (35.96 ± 1.56 μm), delta-catenin cDNA (49.14 ± 1.72 μm; p < 0.0001), and delta-
catenin shRNA (24.98 ± 1.13 μm; p < 0.0001). C, Average dendrite density of neurons expressing GFP 
(16.69 ± 1.26), delta-catenin cDNA (30.90 ± 2.03; p < 0.0001), and delta-catenin shRNA (14.56 ± 1.43; 
p < 0.0001). D, Sholl analysis of dendrite morphology for control, delta-catenin overexpressing, and 
delta-catenin shRNA-expressing neurons. Relative to GFP-expressing cells, neurons overexpressing 
delta-catenin possessed significantly more dendrites at 25μm to 70μm from the soma (p ≤ 0.0001) 
and from 70μm to 110μm from the soma (p < 0.05). *** p ≤ 0.0001. Error bars indicate SEM. For B, 











Figure 16. Validation of shRNA-mediated knockdown of delta-catenin. 
 
HEK293 cells were treated with a previously published shRNA targeting delta-catenin. At 48hrs post-
transfection, no delta-catenin was detected via Western blotting. HEK293 cells represent an 
acceptable system to test shRNA in as these cells transfect readily (unlike primary neurons) and are 















Figure 17. Magi1 expression contributes to and is required for dendrite elongation.  
 
Primary rat hippocampal neurons were transfected at 3DIV and imaged at 7DIV to quantify dendritic 
morphology. A, Representative images of 7DIV rat hippocampal neurons transfected with GFP 
(Control), Magi1 cDNA, or Magi1 shRNA. B, Quantification of average dendrite length of neurons 
expressing GFP (35.96 ± 1.56 μm), Magi1 cDNA (60.98±2.69 μm; p<0.0001), and Magi1 shRNA 
(21.72±0.98; p<0.0001). C, Average dendrite density was not significantly affected by expression of 
Magi1 cDNA (20.5±1.04; p=0.132) or Magi1 shRNA (17.92±2.01; p=0.785) when compared to GFP 
controls (16.69±1.26). D, Sholl analysis of dendrite morphology for control, Magi1 overexpressing, 
and Magi1 shRNA-expressing neurons. Relative to GFP-expressing cells, neurons overexpressing 
Magi1 possessed significantly more dendrites at 35μm to 130μm from the soma (p < 0.05), 
indicating the presence of longer dendrites. Conversely, neurons subjected to shRNA-mediated 
knockdown of Magi1 developed significantly fewer dendrites at 15μm and 30μm to 40μm (p < 0.05). 
*** p ≤ 0.0001. Error bars indicate SEM. For all conditions in A-C n ≥ 12 neurons, for D, n = 6. Scale 













Figure 18. Validation of shRNA-mediated knockdown of Magi1. 
 
HEK293 cells were treated with shRNA targeting human/mouse/rat Magi1. At 48hrs post-
transfection, a significant knockdown of Magi1 was observed via Western blotting. The shRNA 




Pdlim5 contributes to dendrite branching during neuronal development: 
In order to elucidate the roles of Pdlim5 in dendrite development, I employed the same techniques 
as with delta-catenin and Magi1. At 7DIV, neurons overexpressing Pdlim5 developed dendrites with 
similar lengths as controls, yet with significant increases in dendritic tree density, as measured by 
sholl analysis and by number of dendritic tips (Figure 19). In order to observe how the dendrites of 
the neurons develop in the presence of reduced levels of Pdlim5, I utilized shRNA-mediated 
knockdown of Pdlim5. As was the case with Magi1, a previously published shRNA sequence 
targeting Pdlim5 did not exist prior to this work. I utilized the same methods described with Magi1 
to generate a Pdlim5 shRNA sequence capable of knocking down expression of the protein in rat, 
mouse, and human cells, and validated this knockdown in HEK293 cells (Figure 20). Unfortunately, 
the best candidate sequence screened only produced a roughly 40% knockdown of Pdlim5 protein 
levels (quantified using densitometry of western blots), though even at this level, a phenotype was 
observed in hippocampal neurons. 
 
Surprisingly, when neurons were knocked-down for Pdlim5, rather than fewer dendrites as had 
been anticipated, longer dendrites formed. This suggests that in addition to promoting branching 
activity in developing dendrites, Pdlim5 may participate in the inhibition of dendritic elongation. I 
wish to remind the reader that the shRNA-mediated knockdown of Pdlim5 was not complete (~40% 
reduction), and thus more complete depletion might produce an effect on dendrite numbers. In any 
case, my current data suggest some cross-talk between the ascribed activities of Pdlim5 (branching) 
and Magi1 (lengthening) during dendrite development, and that Pdlim5 may exercise more limited 
















Figure 19. Pdlim5 expression contributes to dendrite branching and restriction of outgrowth.  
 
Primary rat hippocampal neurons were transfected at 3DIV and imaged at 7DIV to quantify dendritic 
morphology. A, Representative images of 7DIV rat hippocampal neurons transfected with GFP 
(Control), Pdlim5 cDNA, or Pdlim5 shRNA. B, Quantification of average dendrite length of neurons 
expressing GFP (35.96 ± 1.56 μm), Pdlim5 cDNA (35.69 ± 1.01 μm; p=0.9916) and Pdlim5 shRNA 
(53.25 ± 2.99 μm; p<0.0001). C, Average dendrite density of neurons expressing GFP (16.69 ± 1.26), 
Pdlim5 cDNA (38.13 ± 3.06; p<0.0001), and Pdlim5 shRNA (16.33 ± 1.61; p<0.0001). D, Sholl analysis 
of dendrite morphology for control, Pdlim5 overexpressing, and Pdlim5 shRNA-expressing neurons. 
Relative to GFP-expressing cells, neurons overexpressing Pdlim5 possessed significantly more 
dendrites at 15μm to 40μm from the soma (p ≤ 0.0001). Conversely, neurons subjected to shRNA-
mediated knockdown of Pdlim5 developed significantly more dendrites at 35μm to 95μm (p < 0.05), 
indicating the presence of longer dendrites. *** p ≤ 0.0001. Error bars indicate SEM. For all 














Figure 20. Validation of shRNA-mediated knockdown of Pdlim5 
 
HEK293 cells were treated with shRNA targeting human/mouse/rat Pdlim5. At 48hrs post-
transfection, a significant knockdown of Pdlim5 was observed via Western blotting. The shRNA 
produced an approximate 40% reduction in Pdlim5 protein levels. While this relatively inefficient 
knockdown of Pdlim5 was sufficient to produce a phenotype in neurons, further study of Pdlim5 





Part Three: Identification of the significance of the phosphorylation state of delta-catenin and 
subsequent interactions with Magi1 and Pdlim5 in dendrite development 
 
Generation of Magi1 and Pdlim5 mutants incapable of binding delta-catenin: 
Given the overlapping roles of Magi1 and Pdlim5 with delta-catenin in dendrite development, and 
the complimentary nature of these roles (branching versus elongation), I wished to determine if 
these functions were dependent upon an interaction with delta-catenin. This required the 
generation of loss-of-function/interaction mutants of Magi1 and Pdlim5 that were incapable of 
binding delta-catenin. To enable me to create these loss-of-function constructs of Magi1 and 
Pdlim5, and with the help of Xiaojiang Chen, Ph.D. (University of Southern California), we identified 
residues in the respective PDZ domains of Magi1 and Pdlim5 required to bind the dephospho versus 
phospho PDZ-binding motif of delta-catenin. Based on solved crystal structures of similar complexes 
as well as computational modeling via threading and docking simulation (see Methods), I was able 
to view, at atomic resolution, predicted interactions of the PDZ5 domain of Magi1, or the sole PDZ 
domain Pdlim5, with the PDZ-binding-motif of delta-catenin. Using this information, I generated 
double-point mutants of Magi1 (H62A, I66Y) and Pdlim5 (H63A, Q67Y), respectively, expected to be 
incapable of binding to the dephospho versus phospho (-6 & -3 serines) form of delta-catenin’s PDZ-
binding motif (Figure 21). I named these double-point mutants Magi1-H62A/I66Y and Pdlim5-
H63A/Q67Y, after the respective mutations in each protein. The loss of these mutants’ ability to 
bind delta-catenin’s PDZ-ligand was confirmed in HEK 293 cells by using the GRA. Unlike their 
respective wild-type proteins, both Magi1-H62A/I66Y and Pdlim5-H63A/Q67Y failed to ectopically 
co-relocalize with delta-catenin directed to the Golgi, suggesting that an interaction between these 







Figure 21. Computational modeling of delta-catenin:Magi1 and delta-catenin:Pdlim5 interactions. 
(Data collected by and used with the permission of Xiaojiang Chen, Ph.D. and Aaron Wolfe - 
University of Southern California) 
 
A, Amino Protein sequences of Human Magi1 PDZ5 and Mouse Pdlim5 PDZ. Residues mutated to 
prevent interaction with delta-catenin are highlighted in red (Magi1: H62A/I66Y; Pdlim5: 
H63A/Q67Y). B, Amino acid schematic of a general PDZ-binding motif and delta-catenin’s PDZ 
binding motif, showing serines at -3 and -6 locations. C-D, Models of the Magi1:delta-catenin (C) and 

























Figure 22. Magi1 and Pdlim5 mutants fail to interact with delta-catenin. 
 
Validation of lack of interaction between mutant Pdlim5 and Magi1 with delta-catenin via a Golgi 
Co-relocalization assay in HEK293 cells. A, WT Pdlim5 (green-top) co-relocalizes with delta-catenin 
(red) to the Golgi, while Pdlim5 - H63A/Q67Y (green-bottom) fails to co-relocalize to the Golgi with 
delta-catenin (red). B, WT Magi1 (green-top) co-relocalizes with delta-catenin (red) to the Golgi, 





Magi1 and Pdlim5 require interaction with delta-catenin to execute roles in dendrites: 
I then asked if the loss of Magi1’s or Pdlim5’s ability to bind delta-catenin altered its respective 
expression-phenotype in hippocampal neurons. Mutant constructs were overexpressed in primary 
rat hippocampal neurons starting at 3DIV, with fixation occurring at 7DIV. Dendrite length and 
density were then measured and compared to wild-type Magi1/Pdlim5 overexpression as well as to 
GFP controls. Interestingly, exogenous Magi1-H62A/I66Y overexpression exhibited considerably less 
impact upon dendrite length at 7DIV when compared to wild-type Magi1 overexpression, and failed 
to induce dendrite elongation (Figure 23). This suggests that the role of Magi1 in dendrite 
development may be mostly dependent on an interaction with delta-catenin’s PDZ-binding motif. 
Likewise, neurons overexpressing exogenous Pdlim5-H63A/Q67Y showed a reduced impact upon 
dendritic tree density relative to neurons expressing exogenous wild-type Pdlim5 (Figure 24). While 
Pdlim5-H63A/Q67Y-expressing neurons did develop denser dendritic trees than GFP controls, their 
resulting reduction in dendrite density relative to wild-type Pdlim5 overexpression is consistent with 
Pdlim5’s role in dendritic branching being partially dependent on its ability to interact with delta-
catenin. Taken together, my findings from the Magi1 and Pdlim5 point mutants further support the 
notion that each protein interacts with delta-catenin as part of mechanistic pathways pertinent to 

















Figure 23. Magi1 expression fails to induce dendrite extension in absence of delta-catenin 
interaction. 
 
A, Representative images of 7DIV primary rat hippocampal neurons expressing Magi1 cDNA and 
Magi1 - H62A/I66Y cDNA. B, Quantification of average dendrite length of neurons expressing GFP 
(35.96 ± 1.56 μm), Magi1 cDNA (60.98±2.69 μm; p<0.0001), and Magi1 - H62A/I66Y cDNA 
(36.97±1.86 μm; p=0.997). Overexpression of Magi1 - H62A/I66Y failed to induce the dendrite 
extension that results from native Magi1 overexpression (p ≤ 0.0001). C, Average dendrite density of 
neurons expressing GFP (16.69±1.26), Magi1 cDNA (20.50±1.04; p=0.0.690) and Magi1 - H62A/I66Y 
cDNA (19.4±2.06; p=0.914). D, Sholl analysis of dendrite morphology for GFP control, Magi1 
overexpressing, and Magi1 mutant (H62A/I66Y) overexpressing neurons. Relative to overexpression 
of native Magi1, neurons overexpressing Magi1 - H62A/I66Y possessed significantly fewer dendrites 
at 40μm (p = 0.0090) and 60μm from the soma (p = 0.0357). Overexpression of Magi1 - H62A/I66Y 
produced no changes in dendrite length/density relative to GFP controls. *** p ≤ 0.0001, * p ≤ 0.05. 





















Figure 24. Impact of Pdlim5 expression on dendrite branching weakens in absence of delta-catenin 
interaction. 
 
A, Representative images of 7DIV primary rat hippocampal neurons expressing Pdlim5 cDNA and 
Pdlim5 - H63A/Q67Y cDNA. B, Quantification of average dendrite length of neurons expressing GFP 
(35.96 ± 1.56 μm), Pdlim5 cDNA (35.69 ± 1.01 μm; p=0.9916), and Pdlim5 - H63A/Q67Y cDNA 
(38.63±1.85 μm; p=0.873). C, Average dendrite density of neurons expressing GFP (16.69±1.26), 
Pdlim5 cDNA (38.13 ± 3.06; p<0.0001), Pdlim5 - H63A/Q67Y cDNA (25.70±2.32; p=0.0491). Neurons 
overexpressing Pdlim5 - H63A/Q67Y failed to increase dendrite density to the extent of native 
Pdlim5 overexpression (p=0.0016). D, Sholl analysis of dendrite morphology for GFP control, Pdlim5 
overexpressing, and Pdlim5 mutant (H63A/Q67Y) overexpressing neurons. Relative to GFP-
expressing cells, neurons overexpressing Pdlim5 - H63A/Q67Y possessed significantly more 
dendrites at 40μm (p = 0.0315) and 50μm from the soma (p = 0.0333). Relative to neurons 
overexpressing native Pdlim5, neurons overexpressing Pdlim5 - H63A/Q67Y developed significantly 
fewer dendrites at 15µm to 25µm from the soma (p < 0.05). *** p ≤ 0.0001, * p ≤ 0.05. Error bars 






Phosphorylation of the PDZ-binding motif of delta-catenin modulates dendritic morphology. 
To better address the functional role of the phosphorylation sites within the PDZ-binding motif of 
delta-catenin, I used my previously described phospho-mutants of delta-catenin. Specifically, the -6 
and -3 position residues in delta-catenin (mouse S1245 and S1242), were mutated to alanine 
(phospho-null) or glutamate (phospho-mimic). To investigate the impact of these mutants on 
dendrite development, I expressed them in developing primary rat hippocampal neuron cultures, 
beginning at 3DIV. Upon fixation and imaging at 7DIV, hippocampal neurons expressing phospho-
null delta-catenin – which preferentially binds Magi1 – developed significantly longer dendrites, with 
little-to-no change in the number of dendrites per neuron when compared to controls (Figure 25). 
This observed morphology was strikingly similar to that following Magi1 overexpression. Conversely, 
when a phospho-mimic delta-catenin was expressed – which preferentially binds Pdlim5 – neurons 
developed strikingly dense dendritic trees relative to controls, with little effect upon dendrite length 
(Figure 25). Thus, the expression of the phospho-mimic of delta-catenin produced similar 
phenotypes as overexpressing Pdlim5, further supporting a related role of these proteins in dendrite 
development. Interestingly, I found both the phospho-null delta-catenin and phospho-mimic delta-
catenin mutants to be extremely toxic to the neurons expressing them. This suggests that 
phosphorylation of delta-catenin is a tightly regulated process underlying key neuronal functions, as 
native delta-catenin (which can be phosphorylated/dephosphorylated in neurons) overexpression 
exhibits no such toxicity. Nonetheless, these data remain consistent with the idea that 
phosphorylation of delta-catenin’s PDZ-binding motif constitutes a phospho-switch that assists in 
determining dendrite morphology, and that this switch is likely to be related to differentially forming 







































Figure 25. Phosphorylation of the PDZ-binding motif of delta-catenin modulates its role in dendrite 
development. 
 
 A, Representative images of 7DIV rat hippocampal neurons transfected with GFP (Control), delta-
catenin cDNA, delta-catenin-EE (phospho-mimic) cDNA, and delta-catenin-AA (phospho-null) cDNA. 
B, Quantification of average dendrite length of neurons expressing vector (35.96 ± 1.56 μm), delta-
catenin cDNA (49.14 ± 1.72 μm; p < 0.0001), delta-catenin-EE (phospho-mimic) cDNA (33.59±0.90 
μm; p=0.601), and delta-catenin-AA (phospho-null) cDNA (61.50±2.286 μm; p<0.0001). C, Average 
dendrite density of neurons expressing vector (16.69 ± 1.26), delta-catenin cDNA (30.90 ± 2.03; 
p<0.0001), delta-catenin-EE (phospho-mimic) cDNA (34.00±2.65; p<0.0001), and delta-catenin-AA 
(phospho-null) cDNA (20.00±1.96; p=0.601). D, Sholl analysis of dendrite morphology for control, 
delta-catenin overexpressing, phospho-mimic delta-catenin overexpressing, and phospho-null delta-
catenin overexpressing neurons. Relative to GFP-expressing cells, neurons overexpressing phospho-
mimic delta-catenin possessed significantly more dendrites at 15μm to 135μm from the soma (p < 
0.05). Conversely, neurons overexpressing phospho-null delta-catenin developed significantly more 
dendrites at 60μm to 75μm (p < 0.05), relative to GFP controls. Neurons overexpressing native delta-
catenin possessed significantly more dendrites at 25μm to 70μm from the soma (p ≤ 0.0001) and 
from 70μm to 110μm from the soma, relative to GFP controls (p < 0.05). *** p ≤ 0.0001. Error bars 





Part Four: Identification of upstream drivers and downstream effectors of delta-catenin PDZ-
binding motif phosphorylation 
 
Glutamate signaling initiates phosphorylation of delta-catenin’s PDZ-binding motif and influences 
its role in dendrite development: 
To assess signaling pathways upstream of the phosphorylation of delta-catenin’s PDZ-binding motif, 
I utilized a combination of two primary antibodies (see Methods). One antibody was directed against 
delta-catenin, while the other recognizes a phospho-MAPK/CDK consensus (PXS*P), which I 
observed within the PDZ-binding motif of delta-catenin. This allowed for specific detection/ 
quantification of phosphorylation of delta-catenin’s PDZ-binding motif at the -6 serine position via 
standard immunoprecipitation/Western Blot techniques (Figure 26). Using this combination of 
antibodies, I found that, in hippocampal neuron cultures, DHPG (a Type 1 mGluR agonist) stimulated 
phosphorylation of delta-catenin’s PDZ-binding motif. Following treatment (7DIV; 25μM DHPG, 15 
minutes), delta-catenin was phosphorylated at levels nearly 13-fold higher than control neurons 
(Figure 27). This is consistent with the possibility that metabotropic glutamate receptors are 
involved in signaling upstream of phosphorylation of delta’s PDZ-binding motif. Interestingly, 
stimulation with CHPG (mGluR5 agonist) also resulted in increased delta-catenin’s phosphorylation 
in neuronal cultures, but to a lesser extent (not shown). Further, the increase in phosphorylation 
following Type 1 mGluR activation was very short-lived, and dissipated within 1 hour of treatment. 
This transient phosphorylation, combined with the noted toxicity of the mutant delta-catenin 
constructs, suggests that delta-catenin may be phosphorylated only at very specific points during 
neuronal development. Given these agonist-induced phosphorylation responses, Type1 mGluRs 
appear to be well poised to modulate phosphorylation of delta-catenin’s PDZ-binding motif, and its 











Figure 26. Validation of specificity of detection method for phosphorylated delta-catenin. 
 
A combination of phospho-MAPK/CDK consensus sequence and delta-catenin antibodies can 
specifically detect phosphorylation of delta-catenin’s PDZ-binding motif. Western blot images of 
HEK293 cells transfected with WT delta-catenin and delta-catenin-AA (phospho-null) cDNA. A 
combination of CST Phospho-MAPK/CDK and Sigma delta-catenin antibodies fails to detect phospho-
























Figure 27. Type 1 mGluR activation is sufficient to drive phosphorylation of delta-catenin. 
 
A, Western blots of immunoprecipitated phospho-delta-catenin from 7DIV rat hippocampal cells 
following treatment with DHPG (20μM; 10 minutes) versus no treatment. B, Quantification of fold-
change in delta-catenin phosphorylation following DHPG treatment in 7DIV rat hippocampal cells. 
Treatment of 7DIV primary neurons with 20μM DHPG for 10 minutes resulted in a nearly 13-fold 







To determine whether DHPG-induced phosphorylation of delta-catenin’s PDZ-binding motif alters 
the delta-catenin:Magi1 or delta-catenin:Pdlim5 complexes, I utilized the prior-noted Proximity 
Ligation Assay (PLA) in neuronal cultures. When 3DIV neurons were subjected to DHPG treatment 
(25μM; 30 minutes), the relative fraction of puncta reporting on the delta-catenin:Magi1 complex 
decreased relative to controls, and conversely, puncta reporting upon the delta-catenin:Pdlim5 
complex were significantly increased (Figure 28). This key experiment, assessing endogenous 
protein interactions in neurons, further implicates glutamate signaling in the phospho-dependent 
switch between the delta-catenin:Magi1 and delta-catenin:Pdlim5 associations during the 
development of neurites/dendrites. Further, these data provide additional evidence for a 
developmentally-relevant interaction between delta-catenin and the PDZ proteins Magi1 and 
Pdlim5 during neuronal development that is regulated via a known modulator of dendrite 
morphology (glutamate). 
 
After observing the induced phosphorylation of delta-catenin’s PDZ-binding motif following Type 1 
mGluR stimulation, I next chose to investigate whether DHPG-induced mGluR signaling (leading to 
phosphorylation of delta-catenin’s PDZ-binding motif) also modulates dendrite morphogenesis. 
Primary hippocampal neurons visualized via transfection with GFP at 3DIV as previously described, 
were treated with DHPG at 7DIV (25μM; 180 minutes). I opted for a longer treatment window to 
allow for morphological changes to occur. No morphological changes were observed after 30 
minutes, despite the phosphorylation levels of delta-catenin having peaked by that time. In 
agreement with published studies (Previtera and Firestein 2015a; Cruz-Martín, Crespo, and Portera-
Cailliau 2012), DHPG-treatment increased dendrite numbers relative to controls (Figure 29). This is 
in line with the phenotypes I observed upon the expression of phospho-mimic delta-catenin 






















Figure 28. Type 1 mGluR activation is sufficient to influence endogenous delta-catenin complexes. 
 
Quantification of puncta/cell detected by a Proximity Ligation Assay (Duolink) in 7DIV rat 
hippocampal neurons. Cells were fixed immediately following treatment (no treatment vs 20μM 
DHPG; 10 minutes) and subjected to the assay. DHPG treatment produced an increase in the 
Pdlim5:delta-catenin complex puncta relative to no treatment (54.20±3.24 vs 20.46±1.41; 
p=0.0007), while simultaneously reducing the amount of Magi1:delta-catenin complex detected per 




















Figure 29. DHPG stimulation induces dendritic branching in hippocampal neurons. 
 
A, Representative images of 7DIV rat hippocampal neurons transfected with GFP and subjected to 
no treatment or 20μM DHPG for 6 hours. For each condition image, representative close-ups of 
dendritic branches are shown. B, Quantification of dendritic density following DHPG treatment 
(23.92±1.06, p=0.0002). n ≥ 12 neurons. C, Sholl analysis of dendrite morphology for control and 
DHPG-treated neurons. Neurons treated with DHPG developed significantly more dendrites than 






Lastly, I sought to identify a kinase downstream of mGluR5, responsible for phosphorylation of 
delta-catenin’s PDZ-binding motif. Because the PDZ-binding motif of delta-catenin contains a 
MAPK/CDK consensus, I focused on select CDK or MAPK members implicated in neuron 
development (Liang et al. 2015; Cheung et al. 2007; Yamasaki, Kawasaki, and Nishina 2012). HEK293 
cells were transfected with delta-catenin and either CDK5 + p35 (positive-acting factor associated 
with CDK5), dnCDK5 + p35, or MKK7. I found that CDK5 + p35 produced the highest relative levels of 
PDZ-binding motif phosphorylation (17-fold increase relative to controls) (Figure 30). While future 
studies are needed to better delineate this pathway as well as to reveal other potential kinases 
upstream of this phosphorylation event, my observations implicate CDK5 as a potential modulator 
of delta-catenin’s association with Pdlim5 versus Magi1, and thereby of branching versus 





















Figure 30. Expression of constitutively-active CDK5 increases relative levels of phospho-delta-
catenin. 
 
Representation of fold-change in levels of phosphorylated delta-catenin relative to total delta-
catenin in response to exogenous co-expression of kinases in HEK293 cells. Co-expression of 
constitutively-active CDK5 and p25c with delta-catenin resulted in a 17-fold increase in the relative 





Delta-catenin, Magi1, and Pdlim5 may modulate dendrite extension/branching through inhibition 
of RhoA: 
Lastly, I considered potential effectors acting downstream of phosphorylation of delta-catenin’s 
PDZ-binding-motif in dendrite development. I focused upon RhoA, since it is inhibited via delta-
catenin as reported in both neuronal and non-neuronal cell types (H. Kim, Han, et al. 2008; H. Kim, 
Oh, et al. 2008; D. Zhang et al. 2014). Further, RhoA inhibition is implicated in the promotion of 
dendritic branching (Ay Nakayama, Harms, and Luo 2000). To compare the relative levels of active 
RhoA across conditions, I utilized an ELISA-based assay (Cytoskeleton, Inc.), and cellular extracts 
from HEK293 cells - since they allow facile expression of Pdlim5, Magi1, and/or delta-catenin 
constructs. Additionally, given the results from my kinase experiments, and the fact that delta-
catenin expression can induce the formation of protrusions in HEK293 cells (Abu-Elneel et al. 2008), 
this cell line appears to have at least some of the components relevant to the delta-catenin pathway 
I am studying in neurons. Relative to cells expressing wild-type delta-catenin, the delta phospho-null 
mutant (S→A at -6 & -3 residue positions; mouse S1245A, S1242A), which favors binding Magi1 
(over Pdlim5), produced no change in the relative levels of active RhoA. In contrast, expression of 
the phospho-mimic delta-catenin (glutamate placed at -6 & -3 positions; S1245E, S1242E), which 
favors binding to Pdlim5, significantly reduced the relative amount of active RhoA (Figure 31). While 
the co-expression of either Magi1 or Pdlim5 with delta-catenin amplified RhoA inhibition relative to 
expressing delta-catenin alone, the co-expression of Pdlim5 with delta-catenin produced the 
greatest inhibition of RhoA. These observations are consistent with the possibility that the extent of 
downstream-inhibition of RhoA, as influenced by distinct delta-catenin complexes (directed by the 
phospho-status of delta-catenin’s PDZ-binding motif), contributes to determining outcomes of 




















Figure 31. Phosphorylation of the PDZ-binding motif of delta-catenin mediates its regulation of RhoA 
activity. 
 
Quantification of levels of active RhoA in HEK293 cells expressing WT delta-catenin (baseline), 
phospho-null delta-catenin (102% of baseline), phospho-mimic delta-catenin (85% of baseline), 











My findings help to link the neural catenin-family protein, delta-catenin, to a phosphorylation-
dependent pathway, driven by mGluR activity, that functions to modulate dendritic morphology 
during neuron development (Figure 32). In this pathway, delta-catenin, when unphosphorylated at 
its PDZ-binding motif, promotes dendrite elongation, whereas delta-catenin that is phosphorylated 
within this motif (serines at -6 and -3 positions relative to terminal valine) instead promotes 
dendritic branching. This work builds on earlier work on the PDZ-binding motif of delta-catenin, 
which demonstrated that this motif recognizes and binds a number of PDZ-domain containing 
proteins in neurons (Yuan et al. 2015; Arikkath et al. 2008a; Ide et al. 1999). Here, I reveal delta-
catenin’s novel binding to the PDZ-domain proteins Magi1 and Pdlim5, each with distinctive roles in 
dendrite development. While this report focuses upon the delta:Magi1 versus delta:Pdlim5 
complexes, I note that phosphorylation of delta’s PDZ-binding motif is likely to affect additional PDZ-
domain interactions. This would expand the relevance of delta’s newly revealed phospho-switch 
beyond what is already a strong indicator here, where two novel delta-catenin interactions are 







Figure 32. Proposed model of delta-catenin signaling during dendrite development.  
 
In the absence of glutamate signaling, delta-catenin remains unphosphorylated at its -3 and -6 
serines, allowing it to bind Magi1, which leads to moderate inhibition of RhoA activity, and 
ultimately to dendrite elongation. In response to glutamate signaling and Type 1 mGluR activation, 
delta-catenin is phosphorylated at its -3 and -6 sites and stops binding Magi1. Instead, delta-catenin 






Delta-catenin in dendrite development 
To study the roles of delta-catenin in dendrite development, I opted to utilize a primary rat 
hippocampal neuron culture model. This was due to the established characterization of dendrite 
morphology and development that has been achieved by the field in this model (Dotti, Sullivan, and 
Banker 1988; Banker 2018). The use of a 2D culture model also facilitated analysis of dendrite 
morphology when compared to in vivo options. Nevertheless, it will be worth validating these 
results in an in vivo model to better understand the full context of delta-catenin’s role in neuronal 
development. 
 
The results of my early work on delta-catenin are in agreement with previous findings. Specifically, I 
found that overexpression of delta-catenin in hippocampal neurons resulted in a significant increase 
in both dendrite length and dendrite branch number. While interesting, these processes (elongation 
and branching) are likely mediated by separate pathways, as they fulfill different needs during 
neuron development and have separate downstream effectors associated with them (Dong, Shen, 
and Bülow 2015). Indeed, my work on delta-catenin supports this theory, as my observations 
suggest that delta-catenin induces dendrite elongation or branching via two separate 
phosphorylation-dependent pathways. Each of these distinct pathways involve a novel interaction 
with either of the PDZ domain-containing proteins, Magi1 and Pdlim5, via the PDZ-binding motif of 
delta-catenin.  
 
My findings build upon previous studies which revealed that delta-catenin functions in both the 
elongation and branching of developing dendrites (Arikkath et al. 2008a; Martinez et al. 2003; 
Matter et al. 2009). Despite the significance of catenin phosphorylation having been previously 
observed, the significance of serine modification of delta-catenin, as well as the roles of specific 
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phosphorylation sites within the protein, have remained largely ignored (H. Kim, Han, et al. 2008; 
Martinez et al. 2003). Martinez et al. showed in 2009 that delta-catenin’s role in dendrite branching 
and elongation appears to be influenced by tyrosine and threonine phosphorylation, though specific 
sites were not identified. Further, the authors reported that the observed phosphorylation of delta-
catenin, in addition to mediating the protein’s roles in dendrite formation, led to the loss of delta-
catenin’s association with PSD-95, an interaction dependent on the PDZ-binding motif of delta-
catenin. Interestingly, the only phosphorylation sites in this motif are serine residues, providing 
further support for the possible significance of phosphorylation events at these sites. Results from 
the protein domain microarray described in this work also show a loss of association with PSD-95, 
but specifically in response to phosphorylation at either the -3 or -6 serine of delta-catenin (data not 
shown). These observations suggest that while phosphorylation of the -3 and -6 serines of delta-
catenin may occur in tandem with tyrosine and threonine phosphorylation events, phosphorylation 
of delta-catenin’s PDZ binding motif is sufficient to determine whether the protein promotes 
dendrite elongation or branching. Taken together, the findings described here serve to elaborate on 
the roles of specific phosphorylation sites within delta-catenin and help to reveal the significance of 
the phosphorylation state of delta-catenin’s PDZ-binding motif in dendrite development. 
 
The conclusions above are also complimented by previous studies on delta-catenin, which report 
that delta-catenin’s function in dendritogenesis requires its PDZ binding-motif as well as its 
association with the PDZ-domain of Erbin. Knockdown of Erbin, or deletion of the PDZ-binding motif 
of delta-catenin, results in the underdevelopment of dendritic trees, presumably due to delta-
catenin failing to be transported to neurites by Erbin (Arikkath et al. 2008a). My results interestingly 
suggest that the delta-catenin:Erbin complex is unaffected by phosphorylation of delta-catenin’s 
PDZ-binding motif (Figure 6B), in common with additional interactions resolved on the PDZ-domain 
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arrays. This suggests that delta-catenin can be transported along developing neurites/dendrites 
regardless of its phosphorylation state, though I believe that these phosphorylation events occur 
locally, at future branch points of dendrites. Additionally, preliminary indications are that most of 
delta’s PDZ-motif interactions are not phospho-dependent like those described here. However, as 
noted above, those that are might collectively contribute to wider phospho-switch effects outside of 
delta-catenin’s associations with Magi1 and Pdlim5. Overall, this work elaborates on previous 
findings in this area of dendrite development and further implicates the PDZ-binding motif of delta-
catenin as a key regulator of dendrite morphology. 
 
Roles of Magi1, Pdlim5, and other PDZ Proteins in dendrite development 
In addition to building upon the known roles of delta-catenin in neuronal development, these 
findings also reveal new roles for PDZ domain-containing proteins in the same context. PDZ domain-
containing proteins have multiple roles in many aspects of neuronal development, ranging from 
membrane organization to cytoskeletal remodeling. For instance, in dendrites, the PDZ domain-
containing RacGEF, TIAM-1, is brought into proximity of the WAVE regulatory complex via a PDZ-
dependent interaction in order to stimulate dendritic branching by elevating F-actin assembly in 
spatially specific regions along dendrites, though the mechanisms underlying specification of branch 
sites remains unknown (Zou et al. 2018). Observations of such proximity-based activity regulation 
may help to shed light on the mechanisms by which PDZ proteins influence the activity of delta-
catenin in dendrites, making approaches such as APEX and Bio-ID, which identify proteins in close 
proximity to a given complex, very appealing for further study of the pathways described in this 
work (Hung et al. 2014; Roux et al. 2018). There are also two well-studied MAGUK family members 
that may have roles intertwined with the function of delta-catenin in certain contexts. As previously 
mentioned, PSD-95 is a MAGUK protein family member that stabilizes AMPA receptors in the 
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postsynaptic density via interactions with Stargazin and other auxiliary proteins in complex with 
these receptors (X. Chen et al. 2015; Schnell et al. 2002). Magi2 (S-SCAM), like PSD-95, is another 
synaptic MAGUK protein that acts as a scaffolding molecule for GluA2-containing AMPA receptors, 
and is believed to play a role in synaptic plasticity (Danielson et al. 2012). Both PSD-95 and Magi2 
have been found to interact with the PDZ-binding motif of delta-catenin (Ide et al. 1999; J. B. 
Silverman et al. 2007). My preliminary findings indicate that much like Magi1, both PSD-95 and 
Magi2 interact only with the unphosphorylated PDZ-binding motif of delta-catenin (PSD-95 data not 
shown). While beyond the scope of this work, given known synaptic roles of MAGUK proteins such 
as PSD-95 and Magi2, as well as PDZ domain-containing proteins in general, my findings suggest that 
these proteins may function, in part, via associations with delta-catenin in regions outside of the 
dendrite. Accordingly, further research is needed upon these proteins in neural development, 
especially within the context of the impact of delta-catenin’s phosphorylation in morphogenesis. 
 
My findings concerning Magi1 further build upon the known roles of MAGUK proteins in neural 
development. Prior to this work, very little was known about the function of Magi1 in neuronal 
development, with the majority of previous work on the Magi proteins in this context being focused 
on the synaptic roles of Magi2 (Stetak et al. 2009; Iida et al. 2004; Meyer et al. 2004). The results 
described in this work reveal a new role of Magi1 in neuronal development, in that it promotes 
dendritic elongation in developing hippocampal neurons. Exogenous Magi1 expression greatly 
increases dendrite length, while the number of dendritic branches appears largely unaffected. 
Magi1 knock-down correspondingly results in neurons with shorter dendrites. These roles in 
dendrite outgrowth appear to be dependent upon association of Magi1 with delta-catenin, as when 
a Magi1 mutant incapable of binding delta-catenin is exogenously expressed, neurons do not 
develop significantly longer dendrites. Moreover, when combined with the observation that delta-
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catenin can be manipulated to promote dendrite elongation over branching, these findings further 
support the notion that dendrite elongation and branching are mediated by distinct pathways. 
 
Much like Magi1, my findings suggest that Pdlim5 functions in the developing dendrite via its 
interaction with delta-catenin. However, unlike Magi1, Pdlim5 promotes dendritic branching rather 
than elongation and interacts only with the phosphorylated PDZ-binding motif of delta-catenin. I 
found that hippocampal neurons overexpressing Pdlim5 develop significantly more dendrites when 
compared to controls, and these neurons exhibit minimal to no changes in overall dendrite length. 
Providing support for the dependency of these roles on association with delta-catenin, exogenous 
expression of a Pdlim5 mutant unable to bind delta-catenin fails to increase dendritic branching to 
the same extent as wild-type Pdlim5. While these findings are consistent with Pdlim5’s role in 
dendritic branching being dependent upon its interaction with the phosphorylated PDZ-binding 
motif of delta-catenin, understanding how this interaction directly regulates the activity off either 
protein will require further study. One potential explanation is that the interaction with Pdlim5 
obstructs certain other proteins from binding delta-catenin, thereby changing its ability to regulate 
downstream effectors. A second possibility is that Pdlim5 brings delta-catenin into close proximity 
with a cohort of proteins that are involved in signaling downstream of delta-catenin activity. While 
both of these explanations can help reveal interesting new members of this pathway, further study 
will be required to identify the compositions of different protein complexes formed with delta-
catenin in the presence or absence of Pdlim5 (and Magi1). Additionally, and unexpectedly, neurons 
partially knocked-down for Pdlim5 did not exhibit reduced dendritic branching, but instead showed 
increased dendrite length. This suggests some cross-talk between the mechanisms underlying 
dendrite branching and elongation, and that Pdlim5 promotes dendrite branching while 
simultaneously inhibiting elongation. This observation is in line with previous studies of Pdlim5 that 
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revealed its role in PMA-induced growth cone collapse, indicating that the protein may play a role in 
outgrowth inhibition (Ren et al. 2015). Because a similar increase in dendrite length was not 
observed with overexpression of a Pdlim5 mutant incapable of interacting with delta-catenin, it 
suggests that the role of Pdlim5 in the inhibition of dendrite outgrowth may be independent from its 
interaction with delta-catenin and subsequent roles in dendrite branching. Taken together, these 
findings reveal a novel role for Pdlim5 in the promotion of dendritic branching and inhibition of 
dendritic elongation, as well as place it in a phosphorylation-dependent pathway that functions to 
mediate dendrite morphology.  
 
Neuronal localization of delta-catenin, Magi1, and Pdlim5 
As mentioned above, delta-catenin, Magi1, and Pdlim5 all localize to the dendrites of neurons 
during development, as observed with standard confocal microscopy. This is in line with the roles of 
these proteins in dendrite elaboration, though I felt that utilizing a higher resolution imaging 
technique might shed more light on the potential mechanisms of action for each of these proteins in 
this process. Indeed, through the use of super-resolution (STORM) confocal microscopy, I have 
revealed for the first time the fine localization patterns of delta-catenin, Magi1, and Pdlim5 along 
the dendrites of cultured hippocampal neurons. Interestingly, unlike standard confocal imaging, 
which suggests a rather diffuse localization of these proteins, STORM imaging has revealed that both 
Magi1 and Pdlim5 localize to very fine filopodia-like structures along the lengths of young dendrites, 
with delta-catenin being present at the base of such structures as well as along the length of the 
dendrite shaft. While both Magi1 and Pdlim5 were present in these structures, the distribution of 
Magi1-positive and Pdlim5-positive filopodia were distinct. The Magi1-positive filopodia appeared to 
be primarily localized to the tips of dendrites, whereas the Pdlim5-positive structures were present 
along the entire length of the dendrite shafts. This observation of “filopodial” localization of these 
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proteins is interesting, as it fits with the belief that neurons (among other cell types) sense their 
environment and undergo morphological changes through the use of fine, highly dynamic 
protrusions from the cell (Leondaritis and Eickholt 2015; Gauthier-Campbell et al. 2004).  
 
In the case of dendrite development, two primary functions of filopodia have been observed during 
branching and outgrowth. At the neurite tip, filopodia of the growth cone function to relay extrinsic 
cues to cytoskeletal regulator proteins in order to promote extension of the neurite/dendrite. 
Similarly, along the dendrite shaft, filopodia have been shown to function as dendritic branch 
precursors, with local increases in Ca2+ triggering a CaM-mediated signaling cascade that results in 
the formation of a dendritic branch (Hou et al. 2015; Leondaritis and Eickholt 2015). Accordingly, it is 
conceivable that some of these filopodia are responding to extrinsic signals to produce highly 
localized pockets of phosphorylated delta-catenin at future dendritic branch points, while others are 
responding to distinct cues to facilitate the outgrowth of an established dendrite in a delta-catenin-
dependent manner. The presence of many of these structures along dendrites suggests that they 
are dynamic, with most of the Pdlim5-positive filopodia never becoming dendritic branches, while 
the enrichment of Magi1-positive filopodia to the tips of dendrites suggests that Magi1 may be 
functioning in the elongation of dendrites via roles in signaling events initiated in these structures. 
Consequently, understanding how the fate of a given protrusion is determined will be essential in 
revealing their roles in dendrite development. Overall, my observations of delta-catenin, Magi1, and 
Pdlim5 localization under super-resolution provide insight into the potential mechanisms by which 
these proteins influence dendrite development. It will be interesting to observe the fates of these 
filopodia (retraction vs. stabilization/growth), as well as identify other proteins and possible 




Phosphorylation of delta-catenin in developing neurons 
Previous analysis of phosphorylation events in the rat brain revealed that both the -6 and -3 serines 
of delta-catenin are phosphorylated in vivo, though the significance of these phosphorylation sites 
were never addressed (Lundby et al. 2012). My findings help to address the function of these 
phosphorylation events, and better describe how delta-catenin modulates dendritic arbor formation 
in hippocampal neurons, and likely that of other neuronal cell types. My data suggest that 
phosphorylation of the -6 and -3 serines of delta-catenin occurs in a glutamate-dependent manner, 
via a signaling cascade initiated by Type1 metabotropic glutamate receptors (mGlur5 and mGluR1). 
In untreated neurons, only a small fraction of delta-catenin appears to be phosphorylated, whereas 
treatment of hippocampal neurons with the Type 1 mGluR agonist DHPG results in an approximate 
13-fold increase in the relative levels of phosphorylated delta-catenin, specifically at the PDZ-binding 
motif. While glutamate may not be the sole upstream driver of this pathway, these findings are 
supported by previous studies on the role of glutamate in dendrite development, which indicate 
that it contributes to dendritic branching during development, as blocking mGluR5 activity during 
early development results in neurons with fewer dendrites (H. Park et al. 2007). Nevertheless, it will 
be interesting to determine if glutamate is the lone extrinsic signal responsible for mediating this 
phosphorylation-dependent regulation of dendrite morphogenesis, or if there are other signals that 
also converge on the phosphorylation of delta-catenin to impact dendrite development. 
 
Analysis of the PDZ-binding motif of delta-catenin revealed it to be a MAPK/CDK consensus 
sequence. In line with this, my results suggest that the kinase CDK5 may be primarily responsible for 
the phosphorylation of the -3 and -6 serines of delta-catenin’s PDZ-binding motif, as co-expression 
of a constitutively-active CDK5 with delta-catenin in HEK293 cells results in a nearly 17-fold increase 
in relative phosphorylation of delta-catenin at its PDZ-binding motif. CDK5 has been previously 
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implicated in dendrite development, as it is expressed in the growth cones of developing neurites, 
with loss of CDK5 function resulting in atypical dendrite morphology in cortical neurons (Margareta 
Nikolic et al. 1996; Ohshima et al. 2007). In primary hippocampal neurons, CDK5 has been shown to 
be required for BDNF-induced dendritic growth as well as activity-dependent dendritic growth 
(Cheung et al. 2007; Liang et al. 2015). Interestingly, CDK5 is also known to be activated by Type1 
metabotropic glutamate receptors (mGlur5 and mGluR1) in mouse neostriatal slices, the same 
receptors that my findings implicate in the phosphorylation of the PDZ-binding motif in delta-
catenin (Liu et al. 2001). Further, CDK5 has been shown to phosphorylate delta-catenin in the 
synapse to regulate delta-catenin’s stabilization of AMPA receptors at the synaptic membrane, 
though these synaptic phosphorylation events are not within the PDZ-binding motif of delta-catenin. 
(Poore et al. 2010). Based on my observations, I propose that CDK5 regulates dendritic branching in 
a glutamate dependent-manner via the phosphorylation of delta-catenin’s PDZ-binding motif. 
However, additional work is required to understand the extent of CDK5 activity in response to 
glutamate signaling, as well as to uncover other kinases that may be responsible for phosphorylation 
of delta-catenin’s PDZ-binding motif during dendrite development. While CDK5 appears to function 
downstream of the Type 1 mGluRs, given the large amount of crosstalk between the signaling 
cascades generated by extrinsic signaling cues in dendrite development, it is possible that additional 
receptors lie upstream of CDK5 in terms of delta-catenin phosphorylation. Additionally, while my 
initial findings ruled out several other MAPK/CDK proteins, it will be worth investigating whether 
CDK5 acts as the sole kinase responsible for phosphorylation of the PDZ-binding motif of delta-
catenin, or if other kinases also display some activity in this regard. Further, given the transient 
nature of the phosphorylation status of delta-catenin following DHPG treatment (levels return to 
baseline within 30 minutes), it is likely that the activity of one or more phosphatases at branch 
points of dendrites function as a counterbalance to CDK5-mediated phosphorylation of delta-
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catenin, though more work will be required to reveal the identity of such proteins. Nevertheless, my 
findings build upon on the known roles of CDK5 activation in dendritic growth, as well as link CDK5-
dependent phosphorylation of delta-catenin to a novel regulatory mechanism of dendritic 
development. 
 
While slightly beyond the scope of my project, a key aspect of the pathway described in this work is 
the initial source of glutamate, and there exist several known potential sources. Primary neurons co-
cultured with glial cells develop significantly more complex dendritic arborizations than those 
cultured in the absence of glial cells (Buard et al. 2010; Procko and Shaham 2010). There also exists 
evidence of glial glutamate release and uptake modulating synaptic activity and dendritic spine 
morphology, further implicating glial cell-derived glutamate signaling as a regulator of neuron 
morphogenesis (Angulo 2004; Verbich et al. 2012). This raises the question of whether the glial cells 
supporting neuron development and function are providing dendritic growth cues via the regulation 
of local glutamate levels.  
 
Indeed, it has been shown that a significant portion of extracellular glutamate in the hippocampus 
(and other areas of the brain) is the result of nonvesicular release from astrocytes, with evidence 
supporting the involvement of glial cysteine-glutamate antiporters in this process (Herrera-
Marschitz et al. 1996; Jabaudon et al. 1999; Baker et al. 2002). However, there is also evidence that 
glia-induced dendritic branching occurs via glutamate-independent mechanisms, suggesting that the 
lack of dendritic branching in neurons cultured without glial cells may not be the result of an 
absence of glutamate release. In this context, it was recently shown that astrocytic Phospholipase 
D1 functions to promote dendritic branching through the production and ultimate secretion of 
phosphatidic acid. This phosphatidic acid release leads to the activation of Protein Kinase A in 
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neurons, which has been identified as a component of several developmental signaling pathways in 
neurons, such as those induced by Semaphorin signaling, and is believed to promote dendritic 
branching (Zhu et al. 2016; Song and Poo 1999; Puram and Bonni 2013). Building on these findings, 
it has similarly been revealed that several glia-derived axonal guidance cues can also mediate 
dendritic outgrowth, including Semaphorin, Netrin, and Slit family members, adding further to the 
list of potential glutamate-independent mechanisms by which glial cells may influence dendrite 
branching in neurons (Furrer et al. 2003; Godenschwege et al. 2002; S. Kim and Chiba 2004; Polleux, 
Morrow, and Ghosh 2000). A second possibility is a neuronal source of glutamate. Recent evidence 
suggests that spontaneous axonal release of glutamate prior to synapse formation plays a significant 
role in establishing the complexity of the dendritic arbor (Andreae and Burrone 2015). Non-synaptic 
glutamate signaling is additionally reported to promote dendritic branching and outgrowth via the 
down-regulation of Bcl11A-L by NMDAR activation, with stimulation of these receptors leading to 
neurite branching, and inhibition promoting neurite outgrowth (Kuo, Chen, and Hsueh 2010). The 
source of glutamate in this pathway is believed to be largely axonal, stemming from extrasynaptic 
diffusion of neurotransmitters in young neurons. Interestingly, this glutamate diffusion is thought to 
occur only during early development, before the formation of synapses, and occurs independently 
of the traditional glutamate transporters found on the surface of glial cells (Demarque et al. 2002). 
While my findings support existing and propose new mechanisms of dendrite development 
downstream of glutamate signaling, a significant amount of work is still needed to fully understand 
how such upstream external cues intersect with the intrinsic morphological signaling pathways that 
underlie dendrite morphology. Identifying the source of glutamate in the pathway described in this 
work will mark an integral point in the furthering of our understanding of dendrite development, as 





Downstream effectors of delta-catenin phosphorylation in dendrite development 
Given that the elaboration of dendritic arborizations is almost entirely dependent on the regulation 
of cytoskeletal remodeling events, it is likely that the phosphorylation of delta-catenin and its 
subsequent association with Magi1 or Pdlim5 lead, in part, to the modulation of at least some of the 
many proteins underlying actin or microtubule dynamics in dendrites. As previously mentioned, the 
Rho family of small GTPases has extensive roles in neurite development and maintenance via 
cytoskeletal remodeling, and are perhaps the best described cytoskeletal regulatory proteins in this 
regard (Govek, Newey, and Van Aelst 2005). Specifically, RhoA activity has been shown to inhibit 
dendritic branching in hippocampal neurons, with expression of a constitutively active RhoA leading 
to neurons forming significantly less complex dendritic arbors (AY Nakayama, Harms, and Luo 2000). 
This is likely to occur through the regulation of actin assembly via ROCK, and/or through the 
inhibition of Cypin expression, a protein that acts to promote microtubule assembly in dendrites (H. 
Chen and Firestein 2007). Additionally, RhoA activity is known to be inhibited by delta-catenin, via 
an interaction with and sequestration of the RhoA activator, p190RhoGEF, ultimately preventing it 
from activating RhoA (H. Kim, Han, et al. 2008). A second Rho family member, Rac1, has been shown 
to function in the formation of dendrite branches, and promotes dendritic branching in developing 
hippocampal neurons (Vadodaria et al. 2013). Cdc42, a third Rho-family GTPase, also promotes 
dendrite formation and elaboration in hippocampal neurons, with expression of a dominant-
negative Cdc42 resulting in a decrease in dendritic elaboration in vivo (Threadgill, Bobb, and Ghosh 
1997; Vadodaria et al. 2013). All three of these GTPases have been found to function as downstream 
effectors of numerous extrinsic signaling cues that mediate dendrite development, with glutamate 
signaling playing a major regulatory role in the activity of the proteins in various contexts. For 
instance, RhoA activity has been shown to be downregulated via activation of the AMPA glutamate 
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receptor during synaptic remodeling (Kang, Guo, and Huganir 2009). There is also evidence 
supporting the activation of Cdc42 by CDK5 during neuronal development, as well as its activation in 
a glutamate-dependent manner in dendritic spines during their formation and remodeling (Cheung 
et al. 2007; Murakoshi, Wang, and Yasuda 2011). Additionally, both Rac1 and Cdc42 are known to be 
activated in response to Type 1 mGluR stimulation via DHPG treatment in hippocampal neurons, 
further implicating these cytoskeletal regulators in glutamate-dependent dendritic branching (Abu-
Elneel et al. 2008). Interestingly, activity of both Cdc42 and Rac1 has been shown to increase in 
response to delta-catenin expression in hippocampal neurons (Abu-Elneel et al. 2008). Further, 
expression of dominant-negative Rac1 in hippocampal neurons prevents increased dendritic spine 
formation in response to delta-catenin overexpression, suggesting that the functions of these 
proteins may be intertwined (Abu-Elneel et al. 2008). However, it is worth noting that other groups 
have reported no change in the activity of either Rac1 or Cdc42 in response to delta-catenin 
expression levels, suggesting that delta-catenin’s impact on dendritic morphology may not be 
dependent on global activation of Rac1 and Cdc42, but rather regulation of these proteins in highly 
localized environments within the cell (Arikkath et al. 2008a; H. Kim, Han, et al. 2008). 
 
Previous findings indicate that the inhibition of RhoA activity by delta-catenin is dependent on the 
phosphorylation of Thr-454 in delta-catenin and the protein’s subsequent interaction with and 
sequestration of p190RhoGEF (H. Kim, Han, et al. 2008). There is also evidence that overexpression 
or loss of delta-catenin may not necessarily affect total levels of active RhoA in neurons, as is the 
case for Rac1 and Cdc42 (Arikkath et al. 2008a). Combined with the contradictory findings by the 
field on delta-catenin’s effect on global levels of Cdc42 and Rac1, these observations suggest that 
delta-catenin’s modulation of Rho-family GTPase activity may depend on microenvironmental 
factors, distributed unevenly within single cells, that promote or inhibit post-translational 
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modifications of delta-catenin, such as phosphorylation. In the work described here, I focused my 
attention upon modulation of GTPase activity in response to the newly discovered phospho-switch 
in delta-catenin’s carboxyl-terminal PDZ-binding motif. While I observe a global decrease in RhoA 
activity in HEK293 cells in response to the exogenous expression of a phospho-mimic delta-catenin 
which preferentially interacts with Pdlim5 (and promotes dendritic branching), I believe that 
phosphorylation of delta-catenin at its -6 and -3 serines normally occurs in highly localized dendritic 
(or other) regions as opposed to throughout a large volume of the neuron, and thus that the total 
cellular levels of RhoA-activity remain largely unaltered under normal conditions. Instead, I posit 
that localized sub-dendritic regions of increased RhoA inhibition arise upon delta:Pdlim5 association 
(phosphorylation of delta -6 and -3 serines), that I conjecture helps to initiate dendritic branching or 
to stabilize branches at these loci. This is in line with some previous findings, which report no global 
changes in Rho-family GTPase activity in response to delta-catenin over expression, as changes in 
the activity of these proteins would still be occurring in specific subcellular environments, regardless 
of delta-catenin expression levels. Even when the delta-catenin overexpression phenotypes are 
taken into consideration, branch points along the dendrites of a neurons represent a minor portion 
of the total cellular volume, meaning that observations of a global change in GTPase activity would 
be inconsistent, or possibly undetectable altogether in most cases. While future work on the 
downstream effectors of the pathway described here is clearly required, I suspect that delta-
catenin’s reported ability to modulate the activity of Rho-family small GTPases, and possibly other 
downstream modulators of microfilaments or microtubules, is linked to delta-catenin’s 
phosphorylation-dependent interactions with Magi1 versus Pdlim5. 
 
As would be anticipated, there are prior examples of catenin-protein functions being dependent 
upon phosphorylation-dependent interactions with partner proteins, though none of these reports 
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have focused on the PDZ-binding motifs of the catenins (Gottardi and Gumbiner 2004; Gu et al. 
2011; Hong, Oh, and McCrea 2016; Nusse and Clevers 2017). I note also that the “phospho-switch” 
mechanism revealed in this work within delta-catenin may also be present in certain additional 
catenin proteins. For example, p0071-catenin possesses an identical PDZ-binding motif to that of 
delta-catenin, inclusive of the noted -6 and -3 serine residues (Izawa et al. 2002). While relatively 
little is known about p0071-catenin, it is known to function in cytokinesis through modulation of 
RhoA activity (Keil et al. 2007). It is conceivable that the regulatory functions of p0071 are also 
mediated, in part, by phosphorylation of its PDZ-binding motif in a fashion similar to that of delta-
catenin. Thus, I view it as probable that the further elucidation of delta-catenin’s phospho-switch 
and its downstream effectors in neurons will shed light upon the function of catenins in other cell 
and tissue types. 
 
While my findings, as well as those of previous studies, suggest that small-GTPases are relevant to 
the functions of delta-catenin in neuronal development, delta-catenin has also been found to 
function independently of these proteins in this context.  Specifically, delta-catenin has been shown 
to promote neurite elongation and branching upon the phosphorylation-dependent binding of 
cortactin, an actin-associated protein that induces actin nucleation through association with the 
Arp2/3 complex (Martinez et al. 2003). Thus, the delta-catenin:Magi1 and delta-catenin:Pdlim5 
complexes and subsequent small-GTPase modulation revealed by my findings may function in 
parallel with the actin nucleation events initiated by a delta-catenin:cortactin complex, or other 
delta-catenin protein complexes, to dynamically mediate dendrite branching and elongation during 
development. It may also be the case that the delta-catenin:Magi1 and delta-catenin:Pdlim5 
complexes are directly influencing delta-catenin’s regulation of cortactin or other cytoskeletal 
regulatory proteins. To more completely understand their mechanisms of action, it will be important 
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in the future to identify additional down-stream effectors of the delta:Magi1 and delta:Pdlim5 
complexes, as well as to identify any potential proteins brought into complex with delta-catenin as a 
result of these associations. Methods such as Split Bio-ID, which can reveal the identity of proteins 
brought into association with a given protein complex (delta-catenin:Pdlim5, for example), will be 
especially useful in this endeavor (Schopp et al. 2017). Finally, it will be informative to probe for the 
role of sub-cellular environments, within individual dendrites, in the modulation of delta-catenin 
phosphorylation and subsequent GTPase regulation. For example, if the pinpointed stimulation of 
mGluRs locally enhances delta-catenin:Pdlim5 complex formation, to contribute to branching versus 
lengthening outcomes, or if more broadly present glutamate increases instead generate intrinsic 
cascades (involving delta-catenin) leading to dendrite branching. Such information will be helpful in 
determining how extrinsic signaling cues functionally converge on intrinsic effectors, such as the 
Rho-family small GTPases. 
 
Potential roles of delta-catenin phosphorylation outside of dendrite development. 
The pathway described in this work was primarily investigated from the perspective of dendrite 
development. However, given the roles of delta-catenin and many PDZ domain-containing proteins 
in the development and maintenance of other neuronal compartments, such as the synapse and 
axon, where effectors such as the Rho-family GTPases play a major role, it is entirely conceivable 
that these proteins function in these areas as well.  
 
While my preliminary findings suggest that overexpression or knockdown of delta-catenin, Pdlim5, 
or Magi1 in hippocampal neurons does not impact dendrite-axon specification (as evidenced by 
manipulations occurring at 1DIV), it will be interesting to reveal whether these proteins play a role in 
axon behavior or morphology in the time after specification. The presence of delta-catenin, Pdlim5, 
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and Magi1 in filopodia-like structures along dendrites, as well as in neurite growth cones, may 
provide clues to the function of these proteins in axon development. As is believed to be the case 
for dendrites, axon branches also originate on dynamic filopodial protrusions, many of which never 
become branches (Kalil and Dent 2014). Additionally, at the growth cones of axons, Pdlim5 has been 
shown to function in the collapse of these structures, thus restricting axon outgrowth (Ren et al. 
2015). The results described here suggest a similar role of Pdlim5 in the restriction of dendrite 
outgrowth, raising the question of whether Pdlim5’s dendritic branching roles also extend to axons. 
Further, a key step in both axon outgrowth and axon branching is the reorganization of actin 
filaments, a process that my findings, as well as those of previous studies, reveal may be influenced 
by delta-catenin (K. Kim et al. 2002; Dent, Gupton, and Gertler 2011). The Rho-family GTPases RhoA 
and Rac1, whose activity has been shown to be regulated by delta-catenin, are both crucial for 
normal axonal growth (Woo and Gomez 2006; Abu-Elneel et al. 2008; H. Kim, Han, et al. 2008). 
Neurons lacking Rac1 exhibit increased stalling in outgrowth and guidance defects in vivo (Hua, 
Emiliani, and Nathans 2015). Axon development is similarly dependent on the appropriate 
regulation of RhoA activity, with RhoA activity being required for activity-dependent axon branching, 
axon regeneration, and the inhibition of axonal outgrowth during guidance (Lehmann et al. 1999; 
Fujita and Yamashita 2014; Hu and Selzer 2017; Ohnami et al. 2008). Taken together, these roles for 
the RhoA GTPases in axon development, combined with the overlap between the cascades 
generated by glutamate signaling and several other extrinsic axonal/dendritic guidance cues 
(described in Introduction), suggests that the pathways governing axon morphology may also 
involve the phosphorylation of delta-catenin and subsequent interactions with Pdlim5 or Magi1. 
Because of the potential overlap in dendritic and axonal roles of the proteins described in this work, 
more research will be required to fully elucidate the extent of the function of these proteins in 
neurite outgrowth and elaboration. 
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At the synapse, specifically the postsynaptic density, there similarly exists potential roles for each of 
these proteins in signal transduction and cytoskeletal remodeling. Both delta-catenin and Pdlim5 
have been implicated in synapse development (Joshua B Silverman et al. 2007; Herrick et al. 2010; 
Kosik et al. 2005). Previous studies have revealed that delta-catenin plays a role in mediating 
activity-induced synaptic remodeling, and is crucial for the formation of an appropriate density of 
dendritic spines along dendrites (Arikkath et al. 2009). Interestingly, these roles appear to be 
dependent on the presence of delta-catenin’s PDZ-binding motif, as deletion of this region results in 
similar phenotypes as loss of delta-catenin in neurons (Arikkath et al. 2009). While the identity of 
the PDZ domain-containing interaction partners tied to these roles of delta-catenin remain largely a 
mystery, both PSD-95 and S-SCAM (Magi2), which have well-established roles in synaptic 
development and maintenance, have been revealed to interact with this region of delta-catenin 
(Schnell et al. 2002; E. Kim and Sheng 2004; Iida et al. 2004; Lu et al. 1999; Ide et al. 1999; Abu-
Elneel et al. 2008). Additionally, Pdlim5 has also been shown to function in the restriction of 
dendritic spine size, a process that is integral to synaptic plasticity in the central nervous system 
(Konietzny, Bär, and Mikhaylova 2017; Herrick et al. 2010). Interestingly, my findings demonstrate 
that both PSD-95 and Magi2 only interact with the unphosphorylated PDZ-binding motif of delta-
catenin, suggesting that phosphorylation of this motif may also be relevant in synaptic 
compartments, as it is in the dendrite. These findings may be directly relevant to the synaptic roles 
of delta-catenin phosphorylation, as the neuronal roles of Magi1 appear to be mostly localized to 
dendrites, but the described roles of Magi2 are conversely largely in the dendritic spine and 
postsynaptic density (Iida et al. 2004; Danielson et al. 2012). Thus, it is conceivable that there exists 
a similar phospho-switch function of delta-catenin at the synapse as what I observe in dendrites, 
although with Magi2 taking the place of Magi1 in this context. Given the synaptic roles of delta-
catenin, Pdlim5, Magi2, and several other PDZ domain-containing proteins that interact with delta-
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catenin, it will be worth investigating the function of delta-catenin phosphorylation in synapse 
development. 
 
To summarize, the results from this study implicate delta-catenin in a novel phosphorylation-
dependent pathway mediating dendrite morphology in hippocampal neurons that occurs through 
delta-catenin’s interactions with Magi1 versus Pdlim5.  My findings provide evidence that this delta-
catenin “phospho-switch” operates during dendrite development, contributing to decisions of 
elongation versus branching, which occur countless times during formation of the CNS (and PNS), as 
well as in neuronal repair and pathological contexts. Further study is needed to determine the 
extent of the significance of this “phospho-switch” in neuronal compartments beyond the dendrite, 












Cell Culture and Transfection of HEK293 cells.  
For most biochemical assays and the Golgi Co-relocalization Assay, I utilized HEK293 cells. This cell 
line was chosen due to its high transfectability and convenient lack of endogenous delta-catenin, 
resulting in an environment where perturbations to delta-catenin will not have to compete with the 
endogenous protein. HEK293 cells were purchased from ATCC and maintained in DMEM cell culture 
media (Sigma-Aldrich) supplemented with 10% FBS (Sigma-Aldrich) and 1x penicillin-streptomycin 
(Life Technologies). Culture media was changed every other day until cells reached 80% confluency, 
at which point they were passaged into a new culture dish, or plated into 6-well plates. HEK293 cells 
were transfected using Lipofectamine 3000 and the manufacturer’s recommended protocol. Cells 
were transfected at 50-60% confluency per well in a 6-well culture plate. For Golgi Co-relocalization, 
cells were fixed and imaged 24 hours after transfection and examined via confocal microscopy. For 
validation of shRNA-mediated knockdowns and for immunoprecipitation analyses, HEK293 cells 
were lysed 24-48 hours post-transfection. Cell lysates were then subjected to the appropriate 
biochemical analyses, as described below. 
 
Cell culture and transfection of neurons.  
Primary hippocampal neurons were kindly provided by Dr. Neal Waxham, and were isolated from rat 
embryos (E18) as previously described (Fischer et al. 2018). For morphological analyses, 
hippocampal neurons were plated in 24-well tissue-culture plates (2x105 cells/well), containing glass 
coverslips coated with 100μg/ml poly-D-lysine (Sigma Aldrich). For biochemical analyses, 
hippocampal neurons were plated in 6-well culture plates (1x106 cells/well) to provide an adequate 
amount of cell lysate for analysis. All hippocampal cultures were maintained in Neurobasal Medium 
(Life Technologies) supplemented with B-27 (Life Technologies), GlutaMAX (Life Technologies), and 
penicillin-streptomycin (Life Technologies) for a total of 7 days for most analyses (Neurons used for 
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characterization of delta-catenin, Magi1, and Pdlim5 expression were grown in culture for up to 28 
days).  For transfections, at 3 days in vitro (DIV), neurons were transfected using Lipofectamine 3000 
with 1µg of plasmid DNA and a modified manufacturer’s protocol (Life Technologies). All cDNA 
transfections for overexpression analyses utilized cDNA in the pCS2 expression vector. All shRNA-
mediated knockdowns utilized the pSUPER shRNA expression vector (Oligoengine). To visualize 
expression of exogenous vectors in culture, all cDNA constructs of delta-catenin, Magi1, and Pdlim5 
were epitope tagged (HA-delta-catenin; Flag-Magi1; and Myc-Pdlim5). To confirm successful 
transfection of shRNA, the pSUPER vector utilized a bicistronic GFP or mOrange fluorescent marker. 
This allowed for efficient identification of transfected neurons without compromising the 
functionality of the transfected shRNA. 
 
DNA Constructs.  
All DNA constructs were cloned into the pCS2 mammalian expression vector by the McCrea 
Laboratory. All truncations, deletions, and site mutations were generated via PCR and confirmed 
with DNA sequencing performed by the MDACC Sequencing Core. Full length delta-catenin 
constructs contain an N-terminal HA epitope tag, and a stop codon immediately following the C-
terminal of delta-catenin, to best preserve the function of the C-terminal PDZ-binding motif. I found 
that the use of a C-terminal epitope tag blocks the DPZ-binding motif from interacting with its target 
PDZ domains of other proteins. The shRNA-resistant delta-catenin construct was obtained from 
Jyothi Arikkath and has been described in previous studies (Arikkath et al. 2008a). Briefly, the 
construct utilizes a series of silent mutations to render it resistant to our delta-catenin shRNA (Also 
provided by Jyothi Arikkath). This delta catenin construct was cloned into a pCS2-HA vector by the 
McCrea Laboratory, and was used as the backbone for the delta-AA and delta-EE shRNA-resistant 
delta-catenin constructs. I opted to use the shRNA-resistant delta-catenin for these mutations, as it 
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would be immediately usable in delta-catenin shRNA-mediated knockdown settings that may be 
desirable to study in the future. All Magi1 constructs in this project utilized a pCS2-FLAG vector, 
while the Pdlim5 constructs used a pCS2-Myc vector. All kinase constructs used (dnCDK5, CDK5, 
p25C, and MKK7) utilized the pcDNA3-GFP expression vector and were kind gifts from Jeff Frost, PhD 
(UTHealth). Vector controls utilized either the pCS2 (+GFP) or pSUPER (+GFP or mOrange) vector. 
 
shRNA Synthesis and validation. 
The Oligoengine pSUPER-GFP and pSUPER-mOrange shRNA vectors were used as the backbone for 
all shRNA constructs utilized in this project. For Magi1 and Pdlim5 shRNA, target sequences 19 
nucleotides in length were identified via the siRNA Wizard v3.1 tool (InvivoGen) and used to 
generate the hairpin RNA that would ultimately be transfected into neurons. Following design, 
Magi1 and Pdlim5 shRNA sequences were purchased from GE Dharmacon, then annealed and 
inserted into the pSUPER-GFP vector following the manufacturer’s protocol (Oligoengine). The delta-
catenin shRNA (pSUPER-mOrange) was a kind gift from Jyothi Arikkath (University of Nebraska) and 
has been validated and published as part of several studies on delta-catenin (Arikkath et al. 2009, 
2008a). All construct sequences were validated via the DNA sequencing facility at MD Anderson 




Knockdown efficiency of each shRNA construct was validated via transient transfection of HEK293 
cells expressing either HA-delta-catenin, FLAG-Magi1, or Myc-Pdlim5 with the respective shRNA 
construct. HEK293 cells were used here because of their high transfectability and the difficulty in 
performing culture-wide biochemical analyses of transfected primary neuron cultures. Cells were 
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allowed to grow for 24-48 hours before lysis. To quantify knockdown efficiency, the cell lysates were 
subjected to western blot analysis. Western blots were quantified using densitometry (ImageJ) to 
calculate a general knockdown efficiency percentage for each shRNA. I noticed a near complete loss 
of delta-catenin protein levels in HEK293 cells transfected with shRNA. Both Magi1 and Pdlim5 
exhibited partial knockdown, with a ~68% loss of Magi1 and ~40% loss of Pdlim5 in shRNA-
expressing cultures. While it will be interesting to achieve a more complete knockdown of Magi1 
and Pdlim5, as demonstrated above, my data show that even a partial knockdown of either protein 
in hippocampal neurons is sufficient to generate morphological changes (Figures 17 and 19).  
 
Protein Domain Microarray: 
The protein domain microarray was conducted by the laboratory of Mark Bedford, PhD at the MD 
Anderson Protein Array and Analysis Core. A comprehensive library of human PDZ protein domains 
was cloned into a pGEX vector by Biomatik (Cambridge, Canada) using gene synthesis to best 
optimize the open reading frames for bacterial expression. Escherichia coli was used to express the 
protein domains as GST fusions, which were purified using glutathione-Sepharose beads. The 
recombinant domains were arrayed onto nitrocellulose-coated glass slides (Oncyte®vid slides, Grace 
Bio-Labs, Bend, OR), using an Aushon 2470 pin microarrayer, as previously described (A. Espejo et al. 
2002). The slides were probed with biotinylated delta-catenin PDZ-binding motif peptides (CPC 
Scientific, Sunnyvale, CA). Following probing, fluorescent signal was detected with a GenePix 4200A 
Microarray Scanner (Molecular Devices). 
 
Identification of critical residues in Magi1:delta-catenin and Pdlim5:delta-catenin complexes: 
Identification of the residues in the PDZ domains of Magi1 and Pdlim5 required to bind the PDZ-
binding motif of delta-catenin was carried out by our collaborator Xiaojiang Chen, at the University 
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of Southern California. In order to generate a rough model for prediction of peptide docking, a 
homology model for mgiPDZ5 was creating using the SWISS-MODEL prediction server (Biasini et al. 
2014; Bienert et al. 2017; Guex, Peitsch, and Schwede 2009; Benkert, Biasini, and Schwede 2011) 
using chain B of the previously reported mgPDZ1 structure (Y. Zhang et al. 2007) that comparatively 
has a sequence identity of 33%. This solution was then used as input into the Rosetta FlexPepDock 
server (London et al. 2011; Raveh, London, and Schueler-Furman 2010), using the placement of the 
bound E6 peptide as a relative starting point and using the default run options recommended by the 
server. Upon confirmation of model convergence, the resulting top solution was then energy 
minimized using the ROSETTArelax application, with a thorough search completed using energy 
parameters guided by the Talaris2014 weighting. Relax parameters were chosen to optimize packing 
and bonding interactions, with mild constraints towards the input coordinates, and largely default 
options were used. The resulting minimized solution was then reported as the standard 
configuration within this manuscript. 
 
Golgi Co-relocalization Assay: 
I found these two delta-catenin complexes to be quite sensitive to the harsh conditions associated 
with cell lysis for traditional methods such as co-immunoprecipitation, causing results obtained from 
these assays to be unreliable. To avoid this issue, I developed a novel protein-protein interaction 
assay, called the Golgi Co-relocalization Assay (GRA). This assay allows for the visualization of 
protein-protein interactions with higher sensitivity and reproducibility than with techniques relying 
on cell lysis. In this GRA, a single protein (delta-catenin) is redirected to the Golgi apparatus, causing 
any interaction partners of the protein to also relocalize to the Golgi. Since GRA avoids detergent 
lysis and wash conditions involved in co-immunoprecipitations, weaker or transient interactions 
have a higher probability of being detected. In order to relocalize delta-catenin to the Golgi, I 
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synthesized a fusion protein consisting of full-length delta-catenin with the known Golgi Localization 
Sequence (GLS - see below) from mTOR fused to the protein’s N-terminus (in order to preserve 
function of the PDZ-binding motif). The reason for using this particular sequence is that it remains 
functional at both the N-terminal and C-Terminal of most proteins, unlike many other organelle 
localization sequences (such as mitochondrial outer membrane localization sequences). Following 
transfection, cells were subjected to a standard immunofluorescence staining protocol, as described 
below, and were qualitatively analyzed for relocalization of potential partner proteins to the Golgi 
with the delta-catenin+GLS fusion protein. Since this assay was performed in HEK293 cells, which 
conveniently lack endogenous delta-catenin, competition of this fusion protein with the endogenous 
protein for interaction partners was not a concern. 







Detection and Quantification of phosphorylated delta-catenin: 
Considering the importance of delta-catenin’s phosphorylation to this project, it was imperative to 
develop a method for detection of changes in relative levels of phosphorylated delta-catenin. 
Phosphorylation of delta-catenin’s PDZ-binding motif was detected through the use of a commercial 
monoclonal rabbit antibody (Cell Signaling Technologies) directed against a known phospho-
MAPK/CDK consensus (PXS*P), that I found to be present within the PDZ-binding motif of delta-
catenin. The consensus serine is present at the -6 residue position counting from delta’s terminal 
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valine (YPASPDSWV). When used alone, this phospho-MAPK/CDK consensus sequence antibody is 
not specific to delta-catenin and will recognize numerous other proteins with similar phosphorylated 
sequences. However, when used in combination with a separate monoclonal delta-catenin specific 
antibody (BD Technologies), I was able to quantify the relative amount of phosphorylation at the -6 
serine position within delta’s PDZ-binding motif. This was accomplished via immunoprecipitation of 
phospho-proteins from cell lysates using the phospho-MAPK/CDK consensus (PXS*P) antibody, 
followed by western blot analysis during which I stained the resulting membranes with a 
monoclonal delta-catenin-specific antibody. The resulting 150kD band on my western blot 
membranes represented the relative amount of delta-catenin with a phosphorylated PDZ-binding 
motif when compared to the total amount of delta-catenin in the lysed cells, allowing for semi-
quantitative analysis of delta-catenin phosphorylation. 
 
I validated the specificity of the p-MAPK/CDK antibody to the -6 serine position within delta-catenin 
by expressing wild-type versus phosho-null (S1242A, S1245A) constructs of delta-catenin in HEK293 
cells, followed by immunoprecipitation and immuno-blotting, as described above (Figure 26). I 
detected phosphorylation in exogenously expressed wild-type delta-catenin, but not in the 
phospho-null point mutant, where the -6 and -3 serines had been mutated to alanine. This suggests 
that the anti-Phospho-MAPK/CDK consensus antibody, when combined with a delta-catenin-specific 
antibody, is capable of specifically reporting upon the relative phosphorylation levels of delta-
catenin’s PDZ-binding motif. 
 
RhoA Activity Assay: 
To quantify changes in RhoA activity, the RhoA G-LISA kit from Cytoskeleton, Inc. was used. For this 
solid phase ELISA-based assay, the manufacturer’s protocol was followed. Briefly, HEK293 cells were 
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cultured and transfected as described above. At 24 hours post transfection, the cells were lysed and 
lysates were subjected to an active RhoA-specific luminescence-based ELISA. Relative luminescence 
was measured with a FLUOstar Omega Microplate Reader (BMG Labtech) and normalized to blanks 
(lysis buffer alone) and compared to controls. 
 
Proximity Ligation Assay: 
To detect direct interactions between endogenous proteins, a Proximity Ligation Assay (PLA) was 
utilized. For this assay, hippocampal neurons were cultured and maintained, as described above, 
until fixation at 7DIV. The PLA kit I used was manufactured by Duolink (now part of Sigma-Aldrich) 
and purchased from Sigma-Aldrich. The manufacturer’s protocol was followed during this assay. 
Briefly, cells were permeabilized, blocked, and incubated with primary antibodies, similar to our 
protocol for immunofluorescence staining. Following primary antibody incubation, the cells were 
washed with PBS, and incubated with Duolink PLA probes, which recognize the primary antibodies, 
before being incubated with a ligase and amplification enzymes to generate a DNA structure which 
is recognized by the fluorescent probes provided with the kit. Finally, cells were incubated with said 
fluorescent probes and imaged using a Nikon T2i Inverted Confocal Microscope with an Apo-Plan 
60x 1.4NA Oil objective at pixel size of 100nm. Stacks were converted to maximum projection 
images for analysis. Puncta were quantified using the Puncta Analyzer plugin for the ImageJ 
software. Puncta/cell ratios were then compared to control groups. 
 
Co-Immunoprecipitation and Western Blots: 
For all immunoblotting assays, cells were cultured, maintained, and transfected as described above. 
For assays involving HEK293 cells, cells were lysed 24-48 hours post-transfection. For those utilizing 
neuronal cultures, cells were lysed at 7DIV (no transfection). Neurons were treated with 
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pharmacological agents (DHPG, Cayman Chemicals) at 7DIV (15 minutes to 3 hours before lysis). For 
co-immunoprecipitation, an established and familiar protocol in the McCrea Lab was followed. 
Following lysis, protein concentrations of cell lysates were measured and equalized using a Bradford 
protein assay (Bio-Rad). Equalized cell lysates were then incubated with primary antibodies in 1.5ml 
conical tubes for 1 hour at 4°C while rotating. After 1 hour, A/G agarose (Santa Cruz 
Biotechnologies) beads were added to each tube and incubated for an additional 1 hour at 4°C while 
rotating. Following this secondary incubation, protein was eluted from beads through the addition 
of 2x Sample Buffer with βME and heated at 95°C for 5 minutes. Eluted immunoprecipitation 
samples, and in the case of western blots, equalized cell lysates, were then loaded into an 8% 
acrylamide gel and ran for 120 minutes. Proteins were then transferred to nitrocellulose membranes 
(GE Whatman) using a Pierce Power Blotter (Thermo Scientific). Resulting protein-loaded 
membranes were then blocked in a TBST + 1% dry milk solution overnight at 4°C. Blocked 
membranes were incubated in primary antibodies overnight at 4°C before being incubated in HRP 
conjugated secondary antibodies (Invitrogen). Lastly, membranes were incubated with SuperSignal 




Immunostaining of HEK293 and primary hippocampal neurons was completed using an established 
and familiar protocol (M. Lee et al. 2014). Briefly, cells cultured on Poly-D-lysine coated coverslips 
were fixed with 4% paraformaldehyde for 10 minutes at room temperature and then permeabilized 
with 0.5% Triton X-100 solution for 15 minutes. Following fixation and permeabilization, cells were 
blocked with PBS containing 1% bovine serum albumin overnight at 4°C. After blocking overnight, 
cells were incubated with indicated primary antibodies overnight at 4°C, and then rinsed three times 
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with fresh PBS for 10 minutes each, followed by an overnight rinse with PBS at 4°C. Cells were then 
incubated with Alexa Fluor fluorescent dye conjugated secondary antibodies (Invitrogen) for 1 hour 
a room temperature, before the cover slips were finally mounted onto glass slides with Vectashield 
anti-fade mounting solution (Vector Laboratories). Prepared cells were visualized using a Nikon T2i 
Inverted Confocal Microscope with an APO-PLAN 60x 1.4NA oil objective. All z-series images were 
acquired at a pixel size of 100nm and a step size of 0.2µm. 
 
Antibodies: 
All anti-HA, -Myc, and -FLAG (mouse monoclonal and rabbit polyclonal) were purchased from Sigma-
Aldrich. The rabbit polyclonal delta-catenin antibody used for immunofluorescence was purchased 
from Sigma-Aldrich, while the mouse monoclonal delta-catenin antibody used for western blot 
analysis was purchased from BD Transduction Laboratories. All Magi1 and Pdlim5 (mouse 
monoclonal and rabbit polyclonal) were purchased from Sigma-Aldrich. The P-MAPK/CDK antibody 
used in delta-catenin phosphorylation assays was purchased from Cell Signaling Technologies.  
 
STORM Imaging: 
The acquisition of super-resolution confocal images was accomplished with the assistance of Dr. 
Adriana Paulucci-Holthauzen and utilized the Nikon N-STORM microscopy system in the MD 
Anderson Genetics Department Microscopy Core. For all super-resolution imaging, the 
manufacturer’s protocol was followed (Nikon N-STORM). Briefly, primary hippocampal neurons 
were isolated, as previously described, and plated onto 35mm MatTek dishes coated with poly-D-
lysine. Cells were fixed for 10 minutes at room temperature with 4% paraformaldehyde, and 
permeabilized with 0.5% Triton X-100 solution for 15 minutes. The cells were then blocked with PBS 
containing 1% bovine serum albumin for 90 minutes at room temperature before incubating 
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overnight at 4°C in primary antibodies (1:500 dilution). The cells were then washed 5 times with PBS 
for 15 minutes each (75 minutes total), followed by an incubation with secondary antibodies (Atto 
488 and Atto 647N) for 1 hour at room temperature (1:500 dilution). Lastly, the cells were washed 
another 5 times with PBS for 15 minutes each (75 minutes total), and finally fixed a second time with 
4% paraformaldehyde (no shaking) for 10 minutes. The cells were then rinsed with PBS 3 times, for 5 
minutes per rinse, and stored in dH2O until ready to image. Cells were never stored for longer than 
24 hours at 4°C after preparation. For imaging, dH2O was replaced with a STORM Imaging Buffer 
containing MEA, as described in the manufacturer’s protocol (Nikon N-STORM - GLOX + MEA 
Imaging Buffer) immediately before imaging, and replaced every two hours to maintain quality of 
imaging. Images were acquired with the Nikon NIS-Elements software and Nikon Eclipse Ti2-E 
microscope, using an Apo-Plan TIRF 100X 1.49 NA objective and STORM 3D lenses. Laser lines 
488nm and 647 were used for excitation of the sample and emission was collected with a Quad 
C161417 TIRF filter set with band pass emitters at 525/50nm, 600/50nm and 700/72nm with a 
collection time of 5000 periods. 
 
Neuronal Morphological Analysis: 
All neurons used in this study were subjected to several measurements of their morphological 
characteristics. All images were captured as z-series with a Nikon T2i Inverted Confocal Microscope, 
as described above. Prior to analysis, NIH ImageJ was used to create a two-dimensional, 
background-subtracted maximum projection image from the confocal Z-series images for each 
neuron. Dendrite number was measured by quantifying the number of dendrite tips per neuron. 
Tips of any protrusion shorter than 5μm were excluded. Dendritic length measurements were made 
by tracing from the cell body to the dendrite tip in ImageJ. For Sholl analysis, maximum projection 
images were converted to binary and subjected to analysis in ImageJ. In the Sholl Analysis plugin, a 
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step size of 5μm was set, with a starting point in the center of the soma. Concentric rings radiating 
from the center point, at the set step size, were used to quantify dendrite morphology as it relates 
to distance from the soma. 
 
Statistical Analysis: 
Data was analyzed using GraphPad Prism. Statistical significance for Sholl data was determined using 
a Two-way ANOVA with Bonferroni post-hoc analysis. For all other comparisons, significance was 
determined using the Student’s t test, using a two-tailed test which assumes unequal variances. 
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